Erectile function rehabilitation with phosphodiesterase type 5 inhibitors in patients following nerve-sparing radical prostatectomy: a comparative efficacy analysis of different course lengths ; Сравнительный анализ эффективности различных по продолжительности курсов реабилитации эректильной функции ингибиторами фосфодиэстеразы 5 типа у пациентов после нервосберегающей радикальной простатэктомии

Συγγραφείς: E. V. Pomeshkin, M. V. Shamin, B. A. Nejmark, Е. В. Помешкин, М. В. Шамин, Б. А. Неймарк

Πηγή: Urology Herald; Том 13, № 1 (2025); 39-47 ; Вестник урологии; Том 13, № 1 (2025); 39-47 ; 2308-6424 ; 10.21886/2308-6424-2025-13-1

Θεματικοί όροι: ингибиторы фосфодиэстеразы 5 типа, radical prostatectomy, nerve-sparing, erectile function, erectile dysfunction, penile rehabilitation, радикальная нервосберегающая простэктомия, эректильная функция, эректильная дисфункция, пенильная реабилитация

Περιγραφή αρχείου: application/pdf

Relation: https://www.urovest.ru/jour/article/view/1009/621; Ficarra V, Novara G, Galfano A, Stringari C, Baldassarre R, Cavalleri S, Artibani W. Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36). BJU Int. 2006;97(2):274-278. DOI:10.1111/j.1464-410X.2005.05893.x; Davison BJ, So AI, Goldenberg SL. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int. 2007;100(4):780-785. DOI:10.1111/j.1464-410X.2007.07043.x; Ракул С.А., Петров С.Б., Иванова М.Д., Петрова Н.Н. Апробация «Универсального опросника качества жизни больных раком предстательной железы». Онкоурология. 2009;5(2):64-73. DOI:10.17650/1726-9776-2009-5-2-64-73; Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol. 1984;56(6):694-697. DOI:10.1111/j.1464-410x.1984.tb06149.x; Walz J, Epstein JI, Ganzer R, Graefen M, Guazzoni G, Kaouk J, Menon M, Mottrie A, Myers RP, Patel V, Tewari A, Villers A, Artibani W. A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update. Eur Urol. 2016;70(2):301-311. DOI:10.1016/j.eururo.2016.01.026; Велиев Е.И., Ванин А.Ф., Котов С.В., Шишло В.К. Современные аспекты патофизиологии и профилактики эректильной дисфункции и кавернозного фиброза после радикальной простатэктомии. Урология. 2009;(2);46-51. PMID: 19526874; Hoyland K, Vasdev N, Adshead J. The use of vacuum erection devices in erectile dysfunction after radical prostatectomy. Rev Urol. 2013;15(2):67-71. PMID: 24082845; PMCID: PMC3784970; Hakky TS, Baumgarten AS, Parker J, Zheng Y, Kongnyuy M, Martinez D, Carrion RE. Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction. Curr Urol Rep. 2014;15(4):393. DOI:10.1007/s11934-014-0393-6; Осадчинский А.Е., Павлов И.С., Котов С.В. Пенильная реабилитация у пациентов после радикальной простатэктомии. Экспериментальная и клиническая урология. 2021;14(3):73-79. DOI:10.29188/2222-8543-2021-14-3-73-79; Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med. 2005;2(5):658-667. DOI:10.1111/j.1743-6109.2005.00117.x; Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, Stief C. Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery. Eur Urol. 2012;62(2):261-272. DOI:10.1016/j.eururo.2012.04.046; Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C, Dickson R, Büttner H. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol. 2014;65(3):587-596. DOI:10.1016/j.eururo.2013.09.051; Celermajer DS. Reliable endothelial function testing: at our fingertips? Circulation. 2008;117(19):2428-2430. DOI:10.1161/CIRCULATIONAHA.108.775155; Peled N, Bendayan D, Shitrit D, Fox B, Yehoshua L, Kramer MR. Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension. Respir Med. 2008;102(12):1791-1796. DOI:10.1016/j.rmed.2008.06.014; Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326. DOI:10.1038/sj.ijir.3900472; Mulhall JP, Goldstein I, Bushmakin AG, Cappelleri JC, Hvidsten K. Validation of the erection hardness score. J Sex Med. 2007;4(6):1626-1634. DOI:10.1111/j.1743-6109.2007.00600.x; Еркович А.А., Алиев Р.Т., Наседкина Т.В., Демиденко Э.С., Хабарова О.И., Нотов И.К., Андреев Ю.Г., Рафф Л.С. Мониторинг ночных пенильных тумесценций у здоровых добровольцев регистратором пенильных тумесценций «Андроскан «МИТ» для установления достоверных границ нормофизиологических значений параметров прибора в условиях многоцентрового исследования. Урология. 2021;(4):61-67. DOI:10.18565/urology.2021.4.61-67; Chung E, Brock G. Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med. 2013;10 Suppl 1:102-111. DOI:10.1111/j.1743-6109.2012.03005.x; Wong C, Louie DR, Beach C. A Systematic Review of Pelvic Floor Muscle Training for Erectile Dysfunction After Prostatectomy and Recommendations to Guide Further Research. J Sex Med. 2020;17(4):737-748. DOI:10.1016/j.jsxm.2020.01.008; Marchioni M, De Francesco P, Castellucci R, Papalia R, Sarikaya S, Gomez Rivas J, Schips L, Scarpa RM, Esperto F. Management of erectile dysfunction following robot-assisted radical prostatectomy: a systematic review. Minerva Urol Nefrol. 2020;72(5):543-554. DOI:10.23736/S0393-2249.20.03780-7; Попов С.В., Орлов И.Н., Гулько А.М., Медведев Г.В., Шемякин И.О., Соломицкий Д.Н., Топузов Т.М., Горелик М.Л., Семенюк А.В. Реиннервация полового члена как новая методика лечения эректильной дисфункции у пациентов после радикальной простатэктомии. Вестник урологии. 2020;8(4):135-144. DOI:10.21886/2308-6424-2020-8-4-135-144; Feng D, Tang C, Liu S, Yang Y, Han P, Wei W. Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis. Int J Impot Res. 2022;34(1):18-36. DOI:10.1038/s41443-020-00364-w; Осадчинский А.Е., Павлов И.С., Котов С.В. Обоснование применения вакуум-профилактики эректильной дисфункции с целью пенильной реабилитации пациентов после нервосберегающей радикальной простатэктомии. Вестник урологии. 2021;9(4):87-94. DOI:10.21886/2308-6424-2021-9-4-87-94; Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. BJU Int. 2013;112(6):844-851. DOI:10.1111/bju.12253; Vasconcelos JS, Figueiredo RT, Nascimento FL, Damião R, da Silva EA. The natural history of penile length after radical prostatectomy: a long-term prospective study. Urology. 2012;80(6):1293-1296. DOI:10.1016/j.urology.2012.07.060; Zhang M, Che JZ, Liu YD, Wang HX, Huang YP, Lv XG, Liu W, Lu MJ. A prospective randomized controlled study on scheduled PDE5i and vacuum erectile devices in the treatment of erectile dysfunction after nerve sparing prostatectomy. Asian J Androl. 2022;24(5):473-477. DOI:10.4103/aja202189; Corona G, Razzoli E, Forti G, Maggi M. The use of phosphodiesterase 5 inhibitors with concomitant medications. J Endocrinol Invest. 2008;31(9):799-808. DOI:10.1007/BF03349261; https://www.urovest.ru/jour/article/view/1009

Διαθεσιμότητα: https://www.urovest.ru/jour/article/view/1009
https://doi.org/10.21886/2308-6424-2025-13-1-39-47

EVALUATION OF THE EFFICACY 5-FLUOROURACIL ON ERECTILE FUNCTION IN PATIENTS UNDER SURGICAL TREATMENT OF BENIGN PROSTATE HYPERPLASIA: ОЦЕНКА ЭФФЕКТИВНОСТИ ПРОФИЛАКТИЧЕСКОГО ПРИМЕНЕНИЯ 5-ФТОРУРАЦИЛА ПРИ ЭРЕКТИЛЬНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ, ОПЕРИРОВАННЫХ ПО ПОВОДУ ДОБРОКАЧЕСТВЕННОЙ ГИПЕРПЛАЗИИ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ

Συγγραφείς: Kairambayev, Ye.М., Bulegenov, T.А., Akimzhanov, K.D., Kuderbayev, M.Т., Neimark, A.I., Smail, Ye.M., Yurkovskaya, O.A., Zhumanbayeva, Zh.М., Glushkova, N.E.

Πηγή: Наука и здравоохранение. :105-110

Θεματικοί όροι: surgery, benign prostatic hyperplasia, эректильная функция, эректильді функция, оперативное вмешательство, 5-фторурацил, 5-fluorouracil, erectile function, доброкачественная гиперплазия предстательной железы, хирургия, қуық асты безінің қатерсіз гиперплазиясы, 3. Good health

Facts, trends, and highlights from the cutting-edge sexuality-focused publications ; Факты, тренды, ремарки из литературы по сексуальности мужчин и женщин

Συγγραφείς: M. I. Kogan, М. И. Коган

Πηγή: Urology Herald; Том 12, № 5 (2024); 5-7 ; Вестник урологии; Том 12, № 5 (2024); 5-7 ; 2308-6424 ; 10.21886/2308-6424-2024-12-5

Θεματικοί όροι: рекомендации, erectile function, erectile dysfunction, recommendations, эректильная функция, эректильная дисфункция

Περιγραφή αρχείου: application/pdf

Relation: https://www.urovest.ru/jour/article/view/952/592; https://www.urovest.ru/jour/article/view/952

Διαθεσιμότητα: https://www.urovest.ru/jour/article/view/952
https://doi.org/10.21886/2308-6424-2024-12-5-5-7

Comparison of the results of surgical treatment using various types of access in patients with prostate cancer: oncological, functional, and financial effectiveness ; Сравнение результатов хирургического лечения больных раком предстательной железы с использованием различных видов доступа: онкологическая, функциональная и финансовая эффективность

Συγγραφείς: K. M. Nyushko, V. M. Perepukhov, B. Ya. Alekseev, O. I. Apolikhin, A. D. Kaprin, A. V. Sivkov, A. V. Koryakin, V. P. Aleshin, К. М. Нюшко, В. М. Перепухов, Б. Я. Алексеев, О. И. Аполихин, А. Д. Каприн, А. В. Сивков, А. В. Корякин, В. П. Алешин

Πηγή: Cancer Urology; Том 20, № 3 (2024); 49-56 ; Онкоурология; Том 20, № 3 (2024); 49-56 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: себестоимость, surgical treatment, radical prostatectomy, retropubic access, laparoscopic access, robot-assisted prostatectomy, oncologic outcome, erectile function, continence, minimally invasive access, quality of life, cost, хирургическое лечение, радикальная простатэктомия, позадилонный доступ, лапароскопический доступ, робот-ассистированная простатэктомия, онкологический результат, эректильная функция, удержание мочи, малоинвазивный доступ, качество жизни

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1814/1556; Шахзадова А.О., Старинский В.В., Лисичникова И.В. Состояние онкологической помощи населению России в 2022 году. Сибирский онкологический журнал 2023;22(5):5–13. DOI:10.21294/1814-4861-2023-22-5-5-13; Carbonara U., Srinath M., Crocerossa F. et al. Robot-assisted radical prostatectomy versus standard laparoscopic radical prostatectomy: an evidence-based analysis of comparative outcomes. World J Urol 2021;39(10):3721–32. DOI:10.1007/s00345-021-03687-5; Hagman A., Lantz A., Carlsson S. et al. Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial. World J Urol 2021;39(9): 3239–49. DOI:10.1007/s00345-021-03662-0; Lantz A., Bock D., Akre O. et al. Functional and oncological outcomes after open versus robot-assisted laparoscopic radical prostatectomy for localised prostate cancer: 8-year follow-up. Eur Urol 2021;80(5):650–60. DOI:10.1016/j.eururo.2021.07.025; Stolzenburg J.U., Holze S., Neuhaus P. et al. Robotic-assisted versus laparoscopic surgery: outcomes from the first multicentre, randomised, patient-blinded controlled trial in radical prostatectomy (LAP-01). Eur Urol 2021;79(6):750–9. DOI:10.1016/j.eururo.2021.01.030; Stolzenburg J.U., Holze S., Arthanareeswaran V.K. et al. Roboticassisted versus laparoscopic radical prostatectomy: 12-month outcomes of the multicentre randomised controlled LAP-01 trial. Eur Urol Focus 2022;8(6):1583–90. DOI:10.1016/j.euf.2022.02.002; Moretti T.B.C., Magna L.A., Reis L.O. Open, laparoscopic, and robot-assisted radical prostatectomy oncological results: a reverse systematic review. J Endourol 2023;37(5):521–30. DOI:10.1089/end.2022.0819; Wang J., Hu K., Wang Y. et al. Robot-assisted versus open radical prostatectomy: a systematic review and meta-analysis of prospective studies. J Robot Sur 2023;17(6):2617–31. DOI:10.1007/s11701-023-01714-8; Ambrosini F., Knipper S., Tilki D. et al. Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients. World J Urol 2024;42(1):131. DOI:10.1007/s00345-024-04824-6; Suh J., Jeong I.G., Jeon H.G. et al. Long-term oncologic outcomes of robot-assisted versus open radical prostatectomy for prostate cancer with seminal vesicle invasion: a multi-institutional study with a minimum 5-year follow-up. J Cancer Res Clin Oncol 2023;149(5):1951–60. DOI:10.1007/s00432-022-04243-3; Rechtman M., Forbes A., Millar J.L. et al. Comparison of urinary and sexual patient-reported outcomes between open radical prostatectomy and robot-assisted radical prostatectomy: a propensity score matched, population-based study in Victoria. BMC Urol 2022;22(1):18. DOI:10.1186/s12894-022-00966-0; Haney C.M., Kowalewski K.F., Westhoff N. et al. Robot-assisted versus conventional laparoscopic radical prostatectomy: a systematic review and meta-analysis of randomised controlled trials. Eur Urol Focus 2023;9(6):930–7. DOI:10.1016/j.euf.2023.05.007; Wu S.Y., Chang C.L., Chen C.I. et al. Comparison of acute and chronic surgical complications following robot-assisted, laparoscopic, and traditional open radical prostatectomy among men in Taiwan. JAMA Netw Open 2021;4(8):e2120156. DOI:10.1001/jamanetworkopen.2021.20156; Labban M., Dasgupta P., Song C. et al. Cost-effectiveness of robotic-assisted radical prostatectomy for localized prostate cancer in the UK. JAMA Netw Open 2022;5(4):e225740. DOI:10.1001/jamanetworkopen.2022.5740; Song C., Cheng L., Li Y. et al. Systematic literature review of costeffectiveness analyses of robotic-assisted radical prostatectomy for localised prostate cancer. BMJ Open 2022;12(9):e058394. DOI:10.1136/bmjopen-2021-058394; Wu S.Y., Chang S.C., Chen C.I. et al. Latest comprehensive medical resource consumption in robot-assisted versus laparoscopic and traditional open radical prostatectomy: a nationwide population-based cohort study. Cancers 2021;13(7):1564. DOI:10.3390/cancers13071564; Lindenberg M.A., Retèl V.P., van der Poel H.G. et al. Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes. Sci Rep 2022;12(1):7658. DOI:10.1038/s41598-022-10746-3; Okhawere K.E., Shih I.F., Lee S.H. et al. Comparison of 1-year health care costs and use associated with open vs robotic-assisted radical prostatectomy. JAMA Netw Open 2021;4(3):e212265. DOI:10.1001/jamanetworkopen.2021.2265; Ploussard G., Grabia A., Barret E. et al. Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic). World J Urol 2022;40(2):419–25. DOI:10.1007/s00345-021-03878-0; Рябов М.А., Котов С.В. Сравнительная оценка кривой обучения радикальной простатэктомии произведенной позадилонной, лапароскопической, промежностной и робот-ассистированной техниками. Вестник урологии 2022;10(2):63–71. DOI:10.21886/2308-6424-2022-10-2-63-71; Grivas N., Zachos I., Georgiadis G. et al. Learning curves in laparoscopic and robot-assisted prostate surgery: a systematic search and review. World J Urol 2022; 40(4):929–49. DOI:10.1007/s00345-021-03815-1; Chahal B., Aydin A., Amin M.S.A. et al. The learning curves of major laparoscopic and robotic procedures in urology: a systematic review. Int J Surg 2023;109(7):2037–57. DOI:10.1097/JS9.0000000000000345; https://oncourology.abvpress.ru/oncur/article/view/1814

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1814
https://doi.org/10.17650/1726-9776-2024-20-3-49-56

Уровни витамина D, половых гормонов и состояние эректильной функции у мужчин молодого и среднего возраста

Συγγραφείς: Bondarenko, V.O., Khyzhnyak, O.О., Minukhin, A.S., Skornyakov, E.I., Dorosh, O.G., Nikolaev, R.S., Sanina, E.M.

Πηγή: Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 5 (2020); 387-391
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 5 (2020); 387-391
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY; Том 16, № 5 (2020); 387-391

Θεματικοί όροι: витамин D, эректильная функция, эстрадиол, тестостерон, сахарный диабет 2-го типа, вітамін D, еректильна функція, естрадіол, цукровий діабет 2-го типу, vitamin D, erectile function, estradiol, testosterone, diabetes mellitus type 2, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://iej.zaslavsky.com.ua/article/download/212741/214983
http://iej.zaslavsky.com.ua/article/view/212741
http://iej.zaslavsky.com.ua/article/download/212741/214983
http://iej.zaslavsky.com.ua/article/view/212741

Comparative analysis of 10-year functional outcomes of robot-assisted radical prostatectomy and radical retropubic prostatectomy. Experience of the Urology Clinic of the A.I. Evdokimov Moscow State University of Medicine and Dentistry ; Сравнительный анализ 10-летних функциональных результатов робот-ассистированной радикальной простатэктомии и радикальной позадилонной простатэктомии. Опыт клиники урологии Московского государственного медико-стоматологического университета им. А.И. Евдокимова

Συγγραφείς: K. K. Ramazanov, K. B. Kolontarev, M. D. Ter-Ovanesov, A. V. Govorov, A. O. Vasilyev, A. S. Kazakov, D. Yu. Pushkar, К. К. Рамазанов, К. Б. Колонтарев, М. Д. Тер-Ованесов, А. В. Говоров, А. О. Васильев, А. С. Казаков, Д. Ю. Пушкарь

Πηγή: Cancer Urology; Том 19, № 2 (2023); 56-65 ; Онкоурология; Том 19, № 2 (2023); 56-65 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: удержание мочи, robot-assisted radical prostatectomy, radical retropubic prostatectomy, erectile function, urinary continence, робот-ассистированная радикальная простатэктомия, радикальная позадилонная простатэктомия, эректильная функция

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1628/1458; Sung H., Ferlay J., Siegel R.L. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209–49. DOI:10.3322/caac.21660; Bhat K.R.S., Moschovas M.C., Sandri M. et al. Stratification of potency outcomes following robot-assisted laparoscopic radical prostatectomy based on age, preoperative potency, and nerve sparing. J Endourol 2021;35:1631–8. DOI:10.1089/end.2021.0141; Пушкарь Д.Ю., Колонтарев К.Б. Робот-ассистированная радикальная простатэктомия. Функциональный результат. Часть I. Хирургия. Журнал им. Н.И. Пирогова 2019;(3):111–20. DOI:10.17116/hirurgia2019031111; Bill-Axelson A., Holmberg L., Garmo H. et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014;370(10):932–42. DOI:10.1056/NEJMoa1311593.; Mottet N., van den Bergh R.C.N., Briers E. et al. EAU-EANMESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 2021;79(2):243–62. DOI:10.1016/j.eururo.2020.09.042; Abbou C.C., Hoznek A., Salomon L. et al. Laparoscopic radical prostatectomy with a remote controlled robot. J Urol 2001;165(6 Pt 1): 1964–6. DOI:10.1097/00005392-200106000-00027; Мосоян М.С., Аль-Шукри С.Х., Ильин Д.М. Пятилетний опыт лечения рака предстательной железы на роботе “Da Vinci”. Нефрология 2016;20(4):103–6.; Рамазанов К.К., Колонтарев К.Б., Генс Г.П. и др. Долгосрочные онкологические и функциональные результаты робот-ассистированной радикальной простатэктомии. Онкоурология 2021;17(3):121–8. DOI:10.17650/1726-9776-2021-17-3-121-128; Ramsay C., Pickard R., Robertson C. et al. Systematic review and economic modelling of the relative clinical benefit and costeffectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess 2012;16(41):1–313. DOI:10.3310/hta16410; Health Quality Ontario. Robotic surgical system for radical prostatectomy: a health technology assessment. Ont Health Technol Assess.Ser 2017;17(11):1–172.; Ilic D., Evans S.M., Allan C.A. et al. Laparoscopic and robotassisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review. BJU Int 2018;121(6):845–53. DOI:10.1111/bju.14062; Nyberg M., Hugosson J., Wiklund P. et al. Functional and oncologic outcomes between open and robotic radical prostatectomy at 24-month follow-up in the Swedish LAPPRO trial. Eur Urol Oncol 2018;1(5): 353–60. DOI:10.1016/j.euo.2018.04.012; Baunacke M., Schmidt M.L., Thomas C. et al. Long-term functional outcomes after robotic vs. retropubic radical prostatectomy in routine care: a 6-year follow-up of a large German health services research study. World J Urol 2020;38(7):1701–9. DOI:10.1007/s00345-019-02956-8; Herlemann A., Cowan J.E., Carroll P.R. et al. Community-based outcomes of open versus robot-assisted radical prostatectomy. Eur Urol 2018;73(2):215–23. DOI:10.1016/j.eururo.2017.04.027; Пушкарь Д.Ю., Говоров А.В., Колонтарев К.Б. Робот-ассистированная хирургия. Вестник Российской академии наук 2019;89(5):466–9. DOI:10.31857/S0869-5873895466-469; Отчет официального представителя компании Intuitive Surgical в России ООО «М.П.А. медицинские партнеры». Доступно по: https://robot-davinci.ru/materialy (дата обращения 30.09.2022).; Prostate cancer: diagnosis and treatment. NICE Guidelines (CG58). 2008. Available at: https://www.nice.org.uk/guidance/cg58.; D’Amico A.V., Whittington R., Malkowicz S.B. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280(11):969–74. DOI:10.1001/jama.280.11.969; Partin A.W., Yoo J., Carter H.B. et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993;150(1):110–4. DOI:10.1016/s0022-5347(17)35410-1; Partin A.W., Kattan M.W., Subong E.N. et al. Combination of prostatespecific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multiinstitutional update. JAMA 1997;277(18):1445–51.; Rosen M.A., Goldstone L., Lapin S. et al. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol 1992;148(2 Pt 1):331–7. DOI:10.1016/s0022-5347(17)36587-4; Herschorn S., Bruschini H., Comiter C. et al. Surgical treatment of urinary incontinence in men. Materials of the 4th International Consultation on Incontinence. Plymouth: Health Publications, 2009. Pp. 37–111.; Tholomier C., Couture F., Ajib K. et al. Oncological and functional outcomes of a large canadian robotic-assisted radical prostatectomy database with 10 years of surgical experience. Can J Urol 2019;26(4):9843–51.; Logigan H., Andras I., Pop C.D. et al. Robotic-assisted radical prostatectomy – the 5-year Romanian experience. J BUON 2015;20(4):1068–73.; https://oncourology.abvpress.ru/oncur/article/view/1628

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1628
https://doi.org/10.17650/1726-9776-2023-19-2-56-65

Is oxytocin an undeservedly forgotten hormone in men? ; Окситоцин – незаслуженно забытый гормон у мужчин?

Συγγραφείς: I. A. Tyuzikov, E. A. Grekov, A. V. Smirnov, И. А. Тюзиков, Е. А. Греков, А. В. Смирнов

Πηγή: Andrology and Genital Surgery; Том 24, № 2 (2023); 66-76 ; Андрология и генитальная хирургия; Том 24, № 2 (2023); 66-76 ; 2412-8902 ; 2070-9781

Θεματικοί όροι: предстательная железа, social behavior, sexual behavior, stress, erectile function, male reproduction, metabolism, prostate gland, социальное поведение, половое поведение, стресс, эректильная функция, мужская репродукция, метаболизм

Περιγραφή αρχείου: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/662/522; Dale H.H. The action of extracts of the pituitary body. Biochem J 1909;4(9):427–47. DOI:10.1042/bj0040427; Du Vigneaud V., Ressler C., Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin J Biol Chem 1953;205(2):949–57. PMID: 13129273.; Циркин В.И., Трухина С.И., Трухин А.Н. Окситоцин: синтез, выделение, метаболизм и регуляция этих процессов (обзор). Журнал медико-биологических исследований 2018;6(3): 270–83. DOI:10.17238/issn2542-1298.2018.6.3.270; Чернышева М.П., Ноздрачев А.Д. Нонапептид окситоцин: соматические и висцеральные функции при некоторых психопатологиях. Психофармакология и биологическая наркология 2009;9(3–4):2574–90.; John S., Jaeggi A.V. Oxytocin levels tend to be lower in autistic children: a meta-analysis of 31 studies. Autism 2021;25(8):2152–61. DOI:10.1177/13623613211034375; Григорьева М.Е., Голубева М.Г. Окситоцин: строение, синтез, рецепторы и основные эффекты. Нейрохимия 2010;27(2):93–101.; Neumann I.D., Maloumby R., Beiderbeck D.I. et al. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 2013;38(10):1985–93. DOI:10.1016/j.psyneuen.2013.03.003; Althammer F., Eliava M., Grinevich V. Central and peripheral release of oxytocin: relevance of neuroendocrine and neurotransmitter actions for physiology and behavior. Handb Clin Neurol 2021;180:25–44. DOI:10.1016/B978-0-12-820107-7.00003-3; Rae M., Lemos Duarte M., Gomes I. et al. Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects. Br J Pharmacol 2022;179(8):1544–64. DOI:10.1111/bph.15481; Kim S.H., Bennett P.R., Terzidou V. Advances in the role of oxytocin receptors in human parturition. Mol Cell Endocrinol 2017;449:56–63. DOI:10.1016/j.mce.2017.01.034; Yao S., Kendrick K.M. Effects of intranasal administration of oxytocin and vasopressin on social cognition and potential routes and mechanisms of action. Pharmaceutics 2022;14(2):323. DOI:10.3390/pharmaceutics14020323; Kendrick K.M., Guastella A.J., Becker B. Overview of human oxytocin research. Curr Top Behav Neurosci 2018;35:321–48. DOI:10.1007/7854_2017_19; Carter C.S., Kenkel W.M., MacLean E.L. et al. Is oxytocin “nature’s medicine”? Pharmacol Rev 2020;72(4):829–61. DOI:10.1124/pr.120.019398; Caldwell H.K. Oxytocin and vasopressin: powerful regulators of social behavior. Neuroscientist 2017;23(5):517–28. DOI:10.1177/1073858417708284; Bartz J.A., Nitschke J.P., Krol S.A., Tellier P.P. Oxytocin selectively improves empathic accuracy: a replication in men and novel insights in women. Biol Psychiatry Cogn Neurosci Neuroimaging 2019;4(12):1042–8. DOI:10.1016/j.bpsc.2019.01.014; Aydogan G., Jobst A., Loy F. et al. The effect of oxytocin on group formation and strategic thinking in men. Horm Behav 2018;100: 100–6. DOI:10.1016/j.yhbeh.2018.02.003; Froemke R.C., Young L.J. Oxytocin, neural plasticity, and social behavior. Annu Rev Neurosci 2021;44:359–81. DOI:10.1146/annurev-neuro-102320-102847; Marsh N., Marsh A.A., Lee M.R., Hurlemann R. Oxytocin and the neurobiology of prosocial behavior. Neuroscientist 2021;27(6):604– 19. DOI:10.1177/1073858420960111; Xu L., Becker B., Kendrick K.M. Oxytocin facilitates social learni ng by promoting conformity to trusted individuals. Front Neurosci 2019;13:56. DOI:10.3389/fnins.2019.00056; Alaerts K., Steyaert J., Vanaudenaerde B. et al. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: an exploratory study with long-term follow-up. Eur Neuropsychopharmacol 2021;43:147–52. DOI:10.1016/j.euroneuro.2020.11.014; Yamasue H., Domes G. Oxytocin and Autism Spectrum Disorders. Curr Top Behav Neurosci 2018;35:449–65. DOI:10.1007/7854_2017_24; Moerkerke M., Peeters M., de Vries L. et al. Endogenous oxytocin levels in autism – a meta-analysis. Brain Sci 2021;11(11):1545. DOI:10.3390/brainsci11111545; Huang Y., Huang X., Ebstein R.P., Yu R. Intranasal oxytocin in the treatment of autism spectrum disorders: a multilevel meta-analysis. Neurosci Biobehav Rev 2021;122:18–27. DOI:10.1016/j.neubiorev.2020.12.028; Lehner M., Skórzewska A., Wisłowska-Stanek A. Sex-related predisposition to post-traumatic stress disorder development – the role of neuropeptides. Int J Environ Res Public Health 2021;19(1):314. DOI:10.3390/ijerph19010314; Carmassi C., Marazziti D., Mucci F. et al. Decreased plasma oxytocin levels in patients with PTSD. Front Psychol 2021;12:612338. DOI:10.3389/fpsyg.2021.612338; Eckstein M., Scheele D., Weber K. et al. Oxytocin facilitates the sensation of social stress. Hum Brain Mapp 2014;35(9): 4741–50. DOI:10.1002/hbm.22508; Carter C.S. Oxytocin and love: myths, metaphors and mysteries. Compr Psychoneuroendocrinol 2021;9:100107. DOI:10.1016/j.cpnec.2021.100107; Pfundmair M., Berthold V. Oxytocin makes inexperienced men more selective in their dating strategy. Compr Psychoneuroendocrinol 2020;4:100017. DOI:10.1016/j.cpnec.2020.100017; Martins D., Dipasquale O., Paloyelis Y. Oxytocin modulates local topography of human functional connectome in healthy men at rest. Commun Biol 2021;4(1):68. DOI:10.1038/s42003-020-01610-z; Flanagan J., Chatzittofis A., Boström A.D.E. et al. High plasma oxytocin levels in men with hypersexual disorder. J Clin Endocrinol Metab 2022;107(5):e1816–e22. DOI:10.1210/clinem/dgac015; Zhao W., Ma X., Le J. et al. Oxytocin biases men to be more or less tolerant of others’ dislike dependent upon their relationship status. Psychoneuroendocrinology 2018;88:167–72. DOI:10.1016/j.psyneuen.2017.12.010; Cera N., Vargas-Cáceres S., Oliveira C. et al. How relevant is the systemic oxytocin concentration for human sexual behavior? A systematic review. Sex Med 2021;9(4):100370. DOI:10.1016/j.esxm.2021.100370; Melis M.R., Argiolas A. Oxytocin, erectile function and sexual behavior: last discoveries and possible advances. Int J Mol Sci 2021;22(19):10376. DOI:10.3390/ijms221910376; Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001;81(2):629–83. DOI:10.1152/physrev.2001.81.2.629; Succu S., Sanna F., Cocco C. et al. Oxytocin induces penile erection when injected into the ventral tegmental area of male rats: role of nitric oxide and cyclic GMP. Eur J Neurosci 2008;28(4):813–21. DOI:10.1111/j.1460-9568.2008.06385.x; Baskerville T.A., Allard J., Wayman C., Douglas A.J. Dopamine oxytocin interactions in penile erection. Eur J Neurosci 2009;30(11):2151–64. DOI:10.1111/j.1460-9568.2009.06999.x; Blechman J., Amir-Zilberstein L., Gutnick A. et al. The metabolic regulator PGC-1α directly controls the expression of the hypothalamic neuropeptide oxytocin. J Neurosci 2011;31(42):14835–40. DOI:10.1523/JNEUROSCI.1798-11.2011; Kumar A., Raut S., Balasinor N.H. Endocrine regulation of sperm release. Reprod Fertil Dev 2018;30(12):1595–603. DOI:10.1071/RD18057; Ivell R., Balvers M., Rust W. et al. Oxytocin and male reproductive function. Adv Exp Med Biol 1997;424:253–64. DOI:10.1007/978-1-4615-5913-9_47; Thackare H., Nicholson H.D., Whittington K. Oxytocin – its role in male reproduction and new potential therapeutic uses. Hum Reprod Update 2006;12(4):437–48. DOI:10.1093/humupd/dmk002; Filippi S., Vignozzi L., Vannelli G.B. et al. Role of oxytocin in the ejaculatory process. J Endocrinol Invest 2003; 26(Suppl 3):82–6. PMID: 2834028.; Lui C., Cui X.G., Wang Y.X. et al. Association between neuropeptide oxytocin and male infertility. J Assist Reprod Genet 2010;27(9–10):525–31. DOI:10.1007/s10815-010-9451-2; Mostafa T., Rashed L.A., Osman I., Marawan M. Seminal plasma oxytocin and oxidative stress levels in infertile men with varicocele. Androl 2015;47(2):209–13. DOI:10.1111/and.12248; Stadler B., Whittaker M.R., Exintaris B., Middendorff R. Oxytocin in the male reproductive tract; the therapeutic potential of oxytocin-agonists and-antagonists. Front Endocrinol (Lausanne) 2020;11:565731. DOI:10.3389/fendo.2020.565731; Kerem L., Lawson E.A. The effects of oxytocin on appetite regulation, food intake and metabolism in humans. Int J Mol Sci 2021;22(14):7737. DOI:10.3390/ijms22147737; Giel K., Zipfel S., Hallschmid M. Oxytocin and eating disorders: a narrative review on emerging findings and perspectives. Curr Neuropharmacol 2018;16(8):1111–21. DOI:10.2174/1570159X15666171128143158; Ong Z.Y., Alhadeff A.L., Grill H.J. Medial nucleus tractus solitarius oxytocin receptor signaling and food intake control: the role of gastrointestinal satiation signal processing. Am J Physiol Regul Integr Comp Physiol 2015;308(9):R800–6. DOI:10.1152/ajpregu.00534.2014; Roberts Z.S., Wolden-Hanson T., Matsen M.E. et al. Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 2017;313(4):R357–71. DOI:10.1152/ajpregu.00169.2017; Deblon N., Veyrat-Durebex C., Bourgoin L. et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One 2011;6(9):e25565. DOI:10.1371/journal.pone.0025565; Blevins J.E., Thompson B.W., Anekonda V.T. et al. Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization. Am J Physiol Regul Integr Comp Physiol 2016;310(7):R640–58. DOI:10.1152/ajpregu.00220.2015; Niu J., Tong J., Blevins J.E. Oxytocin as an anti-obesity treatment. Front Neurosci 2021;15:743546. DOI:10.3389/fnins.2021.743546; Hong S.M., Ko J.K., Moon J.J., Kim Y.R. Oxytocin: a potential therapeutic for obesity. J Obes Metab Syndr 2021;30(2):115–23. DOI:10.7570/jomes20098; Breuil V., Trojani M.C., Ez-Zoubir A. Oxytocin and bone: review and perspectives. Int J Mol Sci 2021;22(16):8551. DOI:10.3390/ijms22168551; Zaidi M., New M.I., Blair H.C. et al. Actions of pituitary hormones beyond traditional targets. J Endocrinol 2018;237(3):R83–R98. DOI:10.1530/JOE-17-0680; Elabd C., Cousin W., Upadhyayula P. et al. Oxytocin is an agespecific circulating hormone that is necessary for muscle maintenance and regeneration. Nat Commun 2014;5:4082. DOI:10.1038/ncomms5082; Natochin Y.V., Golosova D.V., Shakhmatova E.I. A new functional role of oxytocin: participation in osmoregulation. Dokl Biol Sci 2018;479(1):60–3. DOI:10.1134/S0012496618020096; McCormack S.E., Blevins J.E., Lawson E.A. Metabolic effects of oxytocin. Endocr Rev 2020;41(2):121–45. DOI:10.1210/endrev/bnz012; Nicholson H.D. Oxytocin: a paracrine regulator of prostatic function. Rev Reprod 1996;1: 9–72. DOI:10.1530/ror.0.0010069; Bodanszky M., Sharaf H., Roy J.B., Said S.I. Contractile activity of vasotocin, oxytocin, and vasopressin on mammalian prostate. Eur J Pharmacol 1992;216(2):311–3. DOI:10.1016/0014-2999(92)90376-F; Demiselle J., Fage N., Radermacher P., Asfar P. Vasopressin and its analogues in shock states: a review. Ann Intensive Care 2020;10(1):9. DOI:10.1186/s13613-020-0628-2; Li Z., Xiao H., Wang K. et al. Upregulation of oxytocin receptor in the hyperplastic prostate. Front Endocrinol (Lausanne) 2018;9:403. DOI:10.3389/fendo.2018.00403; Assinder S.J., Nicholson H.D. Effects of steroids on oxytocin secretion by the human prostate in vitro. Int J Androl 2004;27(1):12–8. DOI:10.1111/j.1365-2605.2004.00439.x; Xu H., Fu S., Chen Y. et al. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway. Clin Sci (Lond) 2017;131(7):595–607. DOI:10.1042/CS20170030; Whittington K., Connors B., King K. et al. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. Prostate 2007;67(10):1132–42. DOI:10.1002/pros.20612; Gould M.L., Nicholson H.D. Changes in receptor location affect the ability of oxytocin to stimulate proliferative growth in prostate epithelial cells. Reprod Fertil Dev 2019;31(6):1166–79. DOI:10.1071/RD18362; Zhong M., Boseman M.L., Millena A.C., Khan S.A. Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway. Mol Cancer Res 2010;8(8):1164–72. DOI:10.1158/1541-7786.MCR-09-0329; https://agx.abvpress.ru/jour/article/view/662

Διαθεσιμότητα: https://agx.abvpress.ru/jour/article/view/662
https://doi.org/10.17650/2070-9781-2023-24-2-66-76

The effectiveness of medical penile rehabilitation after radical prostatectomy ; Эффективность медикаментозной пенильной реабилитации после радикальной простатэктомии

Συγγραφείς: E. V. Pomeshkin, S. V. Popov, I. N. Orlov, M. V. Shamin, E. S. Kagan, Е. В. Помешкин, С. В. Попов, И. Н. Орлов, М. В. Шамин, Е. С. Каган

Πηγή: Andrology and Genital Surgery; Том 24, № 4 (2023); 100-110 ; Андрология и генитальная хирургия; Том 24, № 4 (2023); 100-110 ; 2412-8902 ; 2070-9781

Θεματικοί όροι: пенильная реабилитация, radical prostatectomy, erectile function, erectile dysfunction, penile rehabilitation, радикальная простэктомия, эректильная функция, эректильная дисфункция

Περιγραφή αρχείου: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/710/555; Sari Motlagh R., Abufaraj M., Yang L. et al. Penile rehabilitation strategy after nerve sparing radical prostatectomy: a systematic review and network meta-analysis of randomized trials. J Urol 2021;205(4):1018–30. DOI:10.1097/JU.0000000000001584; Carrier J., Edwards D., Harden J. Men’s perceptions of the impact of the physical consequences of a radical prostatectomy on their quality of life: a qualitative systematic review. JBI Database System Rev Implement Rep 2018;16(4):892–972. DOI:10.11124/JBISRIR-2017-003566; Liu C., Lopez D.S., Chen M., Wang R. Penile rehabilitation therapy following radical prostatectomy: a meta-analysis. J Sex Med 2017;14(12):1496–503. DOI:10.1016/j.jsxm.2017.09.020; Попов С.В., Орлов И.Н., Гулько А.М. и др. Современные подходы к пенильной реабилитации после радикальной простатэктомии. Экспериментальная и клиническая урология 2020;(3):88–94. DOI:10.29188/2222-8543-2020-12-3-88-94; Trindade J.C.S., Viterbo F., Trindade A.P. et al. Long-term follow-up of treatment of erectile dysfunction after radical prostatectomy using nerve grafts and end-to-side somatic-autonomic neurorrhaphy: a new technique. BJU Int 2017;119(6):948–54. DOI:10.1111/bju.13772; Daeschler S.C., Harhaus L., Schoenle P. et al. Ultrasound and shock-wave stimulation to promote axonal regeneration following nerve surgery: a systematic review and meta-analysis of preclinical studies. Sci Rep 2018;8(1):3168. DOI:10.1038/s41598-018-21540-5; Philippou Y.A., Jung J.H., Steggall M.J. et al. Penile rehabilitation for postprostatectomy erectile dysfunction. Cochrane Database Syst Rev 2018;10(10):CD012414. DOI:10.1002/14651858.CD012414.pub2; Осадчинский А.Е., Павлов И.С., Котов С.В. Пенильная реабилитация у пациентов после радикальной простатэктомии. Экспериментальная и клиническая урология 2021;14(3):73–9. DOI:10.29188/2222-8543-2021-14-3-73-79; Salonia A., Burnett A.L., Graefen M. et al. Prevention and management of postprostatectomy sexual dysfunctions. Part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol 2012;62(2):273–86. DOI:10.1016/j.eururo.2012.04.047; Nehra A., Grantmyre J., Nadel A. et al. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol 2005;173(6):2067–71. DOI:10.1097/01.ju.0000158456.41788.93; Montorsi F., Nathan Н.Р., McCullough A. et al. Tadalafil in the treat ment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004;172(3):1036–41. DOI:10.1097/01.ju.0000136448.71773.2b; Montorsi F., Brock G., Stolzenburg J.U. et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol 2014;65(3):587–96. DOI:10.1016/j.eururo.2013.09.051; Wong C., Louie D.R., Beach C.J. Systematic review of pelvic floor muscle training for erectile dysfunction after prostatectomy and recommendations to guide further research. J Sex Med 2020;17(4):737–48. DOI:10.1016/j.jsxm.2020.01.008; Marchioni M., De Francesco P., Castellucci R. et al. Management of erectile dysfunction following robot-assisted radical prostatectomy: a systematic review. Minerva Urol Nefrol 2020;72(5):543–54. DOI:10.23736/S0393-2249.20.03780-7; Feng D., Tang C., Liu S. et al. Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis. Int J Impot Res 2022;34(1):18–36. DOI:10.1038/s41443-020-00364-w; Celermajer D.S. Reliable endothelial function testing: at our fingertips? Circulation 2008;117(19):2428–30. DOI:10.1161/CIRCULATIONAHA.108.775155; Peled N., Bendayan D., Shitrit D. et al. Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension. Respir Med 2008;102(12):1791–6. DOI:10.1016/j.rmed.2008.06.014; Rosen R.C., Cappelleri J.C., Smith M.D. et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11(6):319–26. DOI:10.1038/sj.ijir.3900472; Mulhall J.P., Goldstein I., Bushmakin A.G. et al. Validation of the erection hardness score. J Sex Med 2007;4(6):1626–34. DOI:10.1111/j.1743-6109.2007.00600.x; Davison B.J., So A.I., Goldenberg S.L. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int 2007;100(4):780–5. DOI:10.1111/j.1464-410x.2007.07043.x; Еркович А.А., Алиев Р.Т., Наседкина Т.В. и др. Мониторинг ночных пенильных тумесценций у здоровых добровольцев регистратором пенильных тумесценций «Андроскан МИТ» для установления достоверных границ нормофизиологических значений параметров прибора в условиях многоцентрового исследования. Урология 2021;4:61–7. DOI:10.18565/urology.2021.4.61-67; Parekh A., Chen M.H., Hoffman K.E. et al. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology 2013;81(1):130–4. DOI:10.1016/j.urology.2012.08.068; Атдуев В.А., Ледяев Д.С., Любарская Ю.О. и др. Сексуальная функция у больных раком предстательной железы перед радикальной простатэктомией. Вестник урологии 2014;2:15–24. DOI:10.17650/1726-9776-2022-18-1-49-57; Lima T.F.N., Bitran J., Frech F.S., Ramasamy R. Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities. Int J Impot Res 2021;33(4):401–9. DOI:10.1038/s41443-020-00374-8; Zhang M., Che J.Z., Liu Y.D. et al. A prospective randomized controlled study on scheduled PDE5i and vacuum erectile devices in the treatment of erectile dysfunction after nerve sparing prostatectomy. Asian J Androl 2022t;24(5):473–7. DOI:10.4103/aja202189; https://agx.abvpress.ru/jour/article/view/710

Διαθεσιμότητα: https://agx.abvpress.ru/jour/article/view/710
https://doi.org/10.17650/2070-9781-2023-24-4-100-110

High-dose-rate brachytherapy as monotherapy for prostate cancer: 5-year results ; Брахитерапия высокой мощности дозы в монорежиме в лечении рака предстательной железы: анализ 5-ти летних результатов.

Συγγραφείς: V. A. Solodkiy, A. Yu. Pavlov, A. D. Tsybulskii, A. G. Dzidzaria, A. S. Sorokin, R. I. Mirzakhanov, В. А. Солодкий, А. Ю. Павлов, А. Д. Цыбульский, А. Г. Дзидзария, А. С. Сорокин, Р. И. Мирзаханов

Πηγή: Cancer Urology; Том 18, № 1 (2022); 58-69 ; Онкоурология; Том 18, № 1 (2022); 58-69 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: эректильная функция, brachytherapy, high-dose-rate brachytherapy, prostate cancer, iridium, quality of life, erectile function, брахитерапия, высокодозная брахитерапия, рак предстательной железы, иридий, качество жизни

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1492/1356; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1037; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1038; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1039; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1040; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1041; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1042; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1043; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1044; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1492/1045; Yamazaki H., Masui K., Suzuki G. et al. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer. Radiother Oncol 2019;132:162–70. DOI:10.1016/j.radonc.2018.10.020.; Crook J.M., Gomez-Iturriaga A., Wallace K. et al. Comparison of healthrelated quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial. J Clin Oncol 2011;29(4):362–8. DOI:10.1200/JCO.2010.31.7305.; Strouthos I., Karagiannis E., Zamboglou N., Ferentinos K. High-doserate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome. Cancer Rep (Hoboken) 2021;5(1):e1450. DOI:10.1002/cnr2.1450.; Johansson B., Olsén J.S., Karlsson L. et al. High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center. J Contemp Brachytherapy 2021;13(3):245–53. DOI:10.5114/jcb.2021.105846.; Soatti C.P., Delishaj D., D’Amico R. et al. High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses – 14 years of singlecentre experience. J Contemp Brachytherapy 2020;12(6):533–9. DOI:10.5114/jcb.2020.101685.; Morton G., McGuffin M., Chung H.T. et al. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. Radiother Oncol 2020;146:90–6. DOI:10.1016/j.radonc.2020.02.009.; Zaorsky N.G., Harrison A.S., Trabulsi E.J. et al. Evolution of advanced technologies in prostate cancer radiotherapy. Nat Rev Urol 2013;10(10):565–79. DOI:10.1038/nrurol.2013.185.; Yoshioka Y., Suzuki O., Isohashi F. et al. High-dose-rate brachytherapy as monotherapy for intermediate- and high-risk prostate cancer: clinical results for a median 8-year follow-up. Int J Radiat Oncol Biol Phys 2016;94(4):675–82. DOI:10.1016/j.ijrobp.2015.05.044.; Behmueller M., Tselis N., Zamboglou N. et al. High-dose-rate brachytherapy as monotherapy for low- and intermediaterisk prostate cancer. Oncological outcomes after a median 15-year follow-up. Front Oncol 2021;11:770959. DOI:10.3389/fonc.2021.770959.; Vanneste B.G., van Limbergen E.J., van Lin E.N. et al. Prostate cancer radiation therapy: what do clinicians have to know? Biomed Res Int 2016;2016: 6829875. DOI:10.1155/2016/6829875.; Vogelius I.R., Bentzen S.M. Metaanalysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news? Int J Radiat Oncol Biol Phys 2013;85(1):89–94. DOI:10.1016/j.ijrobp.2012.03.004.; King C.R. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models. Brachytherapy 2002;1(4):219–26. DOI:10.1016/S1538-4721(02)00101-0.; Martell K., Kollmeier M.A. Complications and side effects of high-dose-rate prostate brachytherapy. Brachytherapy 2021;20(5):966–75. DOI:10.1016/j.brachy.2020.10.007.; https://oncourology.abvpress.ru/oncur/article/view/1492

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1492
https://doi.org/10.17650/1726-9776-2022-18-1-58-69

Efficacy of different types of radical prostatectomy in patients with localized prostate cancer ; Эффективность различных видов радикальной простатэктомии у пациентов с локализованным раком предстательной железы

Συγγραφείς: M. V. Shamin, P. S. Kyzlasov, E. V. Pomeshkin, E. A. Bezrukov, М. В. Шамин, П. С. Кызласов, Е. В. Помешкин, Е. А. Безруков

Πηγή: Cancer Urology; Том 18, № 1 (2022); 49-57 ; Онкоурология; Том 18, № 1 (2022); 49-57 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: эректильная дисфункция, radical prostatectomy, erectile function, erectile dysfunction, радикальная простэктомия, эректильная функция

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1452/1357; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1452/990; Mottet N., Bellmunt J., Bolla M. et al. EAU-ESTRO-SIOG guidelines on prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 2017;71(4):618–29. DOI:10.1016/j.eururo.2016.08.003.; Wang X., Wu Y., Guo J. et al. Oncological safety of intrafascial nerve-sparing radical prostatectomy compared with conventional process: a pooled review and metaregression analysis based on available studies. BMC Urol 2019;19(1):41. DOI:10.1186/s12894-019-0476-2.; Rassweiler J. Intrafascial nerve-sparing laproscopic radical prostatectomy: do we really preserve relevant nerve-fibres? Eur Urol 2006;49(6):955–7. DOI:10.1016/j.eururo.2006.03.053.; Ficarra V., Novara G., Galfano A. et al. Twelve-month selfreported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36). BJU Int 2006;97(2):274–8. DOI:10.1111/j.1464-410x.2005.05893.x.; Davison B.J., So A.I., Goldenberg S.L. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int 2007;100(4):780–5. DOI:10.1111/j.1464-410x.2007.07043.x.; Ракул С.А., Петров С.Б., Иванова М.Д., Петрова Н.Н. Апробация «Универсального опросника качества жизни больных раком предстательной железы». Онкоурология 2009;(2):64–73.; Няхин В.А. Функциональные результаты и качество жизни пациентов после радикальной позадилонной простатэктомии. Дис. … канд. мед. наук. М., 2007.; Rosen R., Riley A., Wagner G. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49(6):822–30. DOI:10.1016/j.urology.2020.04.071.; Goldstein I., Mulhall J., Bushmakin A. et al. The erection hardness score and its relationship to successful sexual intercourse. J Sex Med 2008;l(10):2374–80. DOI:10.1111/j.1743-6109.2008.00910.x.; Карнаух П.А., Яйцев С.В., Важенин А.В. и др. Профилактика и лечение эректильной дисфункции у пациентов после радикальной нервосберегающей простатэктомии. Вестник урологии 2015; (4):50–64.; Salonia A., Burnett A., Graefen M. et al. Preservation and management of prostatectomy sexual dysfunction Part 2: Recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol 2012;62(2):273–86. DOI:10.1016/j.eururo.2012.04.047.; Глыбочко П.В., Матюхов И.П., Аляев Ю.Г. и др. Сексуальная функция пациентов, перенесших радикальную простатэктомию: современный взгляд на проблему. Урология 2015;(2):112–6.; Мазо Е.Б., Гамидов С.И., Овчинников Р.И. и др. Новые аспекты патогенеза, профилактики и лечения эректильной дисфункции у больных после радикальной простатэктомии. Consilium Medicum 2004;6(7):506–9.; Пушкарь Д.Ю., Бормотин А.В., Говоров A.B. Лечение эректильной дисфункции у пациентов, перенесших prostate cancer; radical prostatectomy; erectile function; erectile dysfunction радикальную позадилонную простатэктомию, с использованием ингибиторов фосфодиэстеразы 5 типа. Качество жизни. Медицина 2007;(5):36–41.; Роюк Р.В. Оптимизация методов диагностики и коррекции осложнений радикальной простатэктомии. Дис. … канд. мед. наук. М., 2007.; Ситников Н.В. Профилактика осложнений и ранняя реабилитация больных после радикальной простатэктомии. Дис. . д-ра мед. наук. М., 2008.; Велиев Е.И., Ванин А.Ф., Котов С.В., Шишло В.К. Современные аспекты патофизиологии и профилактики эректильной дисфункции и кавернозного фиброза после радикальной простатэктомии. Урология 2009;(2):46–51.; Котов С.В. Профилактика кавернозного фиброза после нервосберегающей радикальной простатэктомии. Дис. … канд. мед. наук. М., 2009.; Briganti A., Gallina A., Suardi N. et al. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification. J Sex Med 2010;7(7):2521–31. DOI:10.1111/j.1743-6109.2010.01845.x.; Черняев В.В., Матвеев В.Б., Волкова М.И. и др. Факторы прогноза биохимического рецидива локализованного и местно-распространенного рака простаты после радикальной простатэктомии. Онкоурология 2012;(4): 58–64.; Атдуев В.А., Ледяев Д.С., Любарская Ю.О. и др. Сексуальная функция у больных раком предстательной железы перед радикальной простатэктомией. Вестник урологии 2014;(2):15–24.; Ball A.J., Gambill B., Fabrizio M.D. et al. Prospective longitudinal comparative study of early health-related quality of life outcomes in patients undergoing surgical treatment for localized prostate cancer: a shortterm evaluation of five approaches from a single institution. J Endourol 2006;20(10):723–31. DOI:10.1089/end.2006.20.723.; Велиев Р.А., Велиев Е.И., Соколов Е.А. Прогностические факторы восстановления эректильной функции у пациентов после радикальной простатэктомии. Экспериментальная и клиническая урология 2020;13(5):60–2. DOI:10.29188/2222-85432020-13-5-60-62.; Martinez-Salamanca J.I., Ramanathan R., Rao S. et al. Second Prize: Pelvic neuroanatomy and innovative approaches to minimize nerve damage and maximize cancer control in patients undergoing robot-assisted radical prostatectomy. J Endourol 2008;22(6):1137–46. DOI:10.1089/end.2008.0097.; Audouin M., Beley S., Cour F. et al. Erectile dysfunction after radical prostatectomy: pathophysiology, evaluation and treatment. Prog Urol 2010;20(3):172–82. DOI:10.1016/j.purol.2009.06.008.; Tewari A., Grover S., Sooriakumaran P. et al. Nerve sparing can preserve orgasmic function in most men after robotic-assisted laparoscopic radical prostatectomy. BJU Int 2012;109(4):596–602. DOI:10.1111/j.1464-410x.2011.10402.x.; Du K., Zhang C., Presson A. et al. Orgasmic function after radical prostatectomy. J Urol 2017;198(2):407–13. DOI:10.1016/j.juro.2017.03.118.; https://oncourology.abvpress.ru/oncur/article/view/1452

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1452
https://doi.org/10.17650/1726-9776-2022-18-1-49-57

Results of the nerve-sparing radical prostatectomy in obese patients ; Результаты нервосберегающей техники радикальной простатэктомии у пациентов с ожирением

Συγγραφείς: E. A. Sokolov, E. I. Veliev, Е. А. Соколов, Е. И. Велиев

Πηγή: Urology Herald; Том 8, № 2 (2020); 43-49 ; Вестник урологии; Том 8, № 2 (2020); 43-49 ; 2308-6424 ; 10.21886/2308-6424-2020-8-2

Θεματικοί όροι: нервосберегающая техника, radical prostatectomy, obesity, erectile function, nerve-sparing technique, радикальная простатэктомия, ожирение, эректильная функция

Περιγραφή αρχείου: application/pdf

Relation: https://www.urovest.ru/jour/article/view/329/250; Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P. EAU-ESTROSIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618‒629. https://dx.doi.org/10.1016/j. eururo.2016.08.003; Wilt TJ, Vo TN, Langsetmo L, Dahm P, Wheeler T, Aronson WJ, Cooperberg MR, Taylor BC, Brawer MK. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. 2020;77(6):713‒724. https://dx.doi.org/10.1016/j. eururo.2020.02.009; Lardas M, Liew M, van den Bergh RC, De Santis M, Bellmunt J, Van den Broeck T, Cornford P, Cumberbatch MG, Fossati N, Gross T, Henry AM, Bolla M, Briers E, Joniau S, Lam TB, Mason MD, Mottet N, van der Poel HG, Rouvière O, Schoots IG, Wiegel T, Willemse PM, Yuan CY, Bourke L. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review. Eur Urol. 2017;72(6):869‒885. https://dx.doi.org/10.1016/j. eururo.2017.06.035; Avulova S, Zhao Z, Lee D, Huang LC, Koyama T, Hoffman KE, Conwill RM, Wu XC, Chen V, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Resnick MJ, Penson DF, Barocas DA. The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study. J Urol. 2018;199(5):1202‒1209. https://dx.doi.org/10.1016/j.juro.2017.12.037; Соколов Е.А., Велиев Е.И., Богданов А.Б. Велиев Р.А., Гончарук Д.А. Онкологическая безопасность нервосберегающей техники радикальной простатэктомии: оценка патоморфологических результатов и безрецидивной выживаемости. Урология. 2020;2:60‒64. https://dx.doi.org/10.18565/urology.2020.2.60-64; Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019;28(11):1917‒1925. https://dx.doi.org/10.1158/1055-9965.EPI-19-0488; Wissing M, Chevalier S, McKercher G, Laprise C, Aprikian S, O’Flaherty A, Scarlata E, Saad F, Carmel M, Lacombe L, Brimo F, Latour M, Ekindi-Ndongo N, Têtu B, Aprikian A. The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer. World J Urol. 2019;37(5):789‒798. https://dx.doi.org/10.1007/s00345-018-2457-6; Гусова З.Р., Дзантиева Е.О. Роль висцерального ожирения и дефицита тестостерона в формировании метаболических нарушений у мужчин. Вестник урологии. 2019;7(3):14‒22. https://dx.doi.org/10.21886/2308-6424- 2019-7-3-14-22; Marzorati C, Monzani D, Mazzocco K, Pavan F, Cozzi G, De Cobelli O, Monturano M, Pravettoni G. Predicting trajectories of recovery in prostate cancer patients undergone Robot-Assisted Radical Prostatectomy (RARP). PLoS One. 2019;14(4):e0214682. https://dx.doi.org/10.1371/journal.pone.0214682; Porcaro AB, Tafuri A, Sebben M, Processali T, Pirozzi M, Amigoni N, Rizzetto R, Shakir A, Cerruto MA, Brunelli M, Siracusano S, Artibani W. High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection. Asian J Androl. 2020;22(3):323‒329. https://dx.doi.org/10.4103/aja.aja_70_19; De Nunzio C, Brassetti A, Simone G, Lombardo R, Mastroianni R, Collura D, Muto G, Gallucci M, Tubaro A. Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study. Prostate Cancer Prostatic Dis. 2018;21(3):438‒445. https://dx.doi.org/10.1038/s41391-018-0054-9; Yu YD, Byun SS, Lee SE, Hong SK. Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy. Sci Rep. 2018;8(1):11962. https://dx.doi.org/10.1038/s41598-018-30473-y; Mason RJ, Boorjian SA, Bhindi B, Rangel L, Frank I, Karnes RJ, Tollefson MK. Examining the association between adiposity and biochemical recurrence after radical prostatectomy. Can Urol Assoc J. 2018;12(7):E331‒E337. https://dx.doi.org/10.5489/cuaj.4923; Pizzol D, Smith L, Fontana L, Caruso MG, Bertoldo A, Demurtas J, McDermott D, Garolla A, Grabovac I, Veronese N. Associations between body mass index, waist circumference and erectile dysfunction: a systematic review and META-analysis. Rev Endocr Metab Disord. 2020 Jan 31. [Epub ahead of print] https://dx.doi.org/10.1007/s11154- 020-09541-0; Neumaier MF, Segall CH Júnior, Hisano M, Rocha FET, Arap S, Arap MA. Factors affecting urinary continence and sexual potency recovery after robotic-assisted radical prostatectomy. Int Braz J Urol. 2019;45(4):703‒712. https://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0704; Beyer B, Kühne K, Böhm K, Schiffmann J, Heinzer H, Michl U, Huland H, Graefen M, Haese A, Steuber T. Roboterassistierte radikale Prostatektomie: Vorteil bei adipösen Männern? ‒ Eine Matched-pair-Analyse [DaVinci robot-assisted laparoscopic prostatectomy: benefit for obese men? ‒ A matchedpair analysis]. Urologe A. 2015;54(1):34‒40. (in German). https://dx.doi.org/10.1007/s00120-014-3589-y; https://www.urovest.ru/jour/article/view/329

Διαθεσιμότητα: https://www.urovest.ru/jour/article/view/329
https://doi.org/10.21886/2308-6424-2020-8-2-43-49

Penile reinnervation as a new technique for treating erectile dysfunction in patients after radical prostatectomy ; Реиннервация полового члена как новая методика лечения эректильной дисфункции у пациентов после радикальной простатэктомии

Συγγραφείς: S. V. Popov, I. N. Orlov, A. M. Gul'ko, G. V. Medvedev, I. O. Shemiakin, D. N. Solomitskiy, T. M. Topuzov, M. L. Gorelik, A. V. Semenyuk, С. В. Попов, И. Н. Орлов, А. М. Гулько, Г. В. Медведев, И. О. Шемякин, Д. Н. Соломицкий, Т. М. Топузов, М. Л. Горелик, А. В. Семенюк

Πηγή: Urology Herald; Том 8, № 4 (2020); 135-144 ; Вестник урологии; Том 8, № 4 (2020); 135-144 ; 2308-6424 ; 10.21886/2308-6424-2020-8-4

Θεματικοί όροι: физиологическая эректильная функция, radical prostatectomy, penile innervation, physiological erectile function, радикальная простатэктомия, реиннервация полового члена

Περιγραφή αρχείου: application/pdf

Relation: https://www.urovest.ru/jour/article/view/398/295; van Poppel H, Everaerts W, Tosco L, Joniau S. Open and robotic radical prostatectomy. Asian J urol. 2019;6(2):125-128. DOI:10.1016/j.ajur.2018.12.002; Schostak M, Miller K, Schrader M. Radical prostatectomy in the 21st century - the gold standard for localized and locally advanced prostate cancer. Front Radiat Ther Oncol. 2008;41:7-14. DOI:10.1159/000139873; Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. DOI:10.3322/caac.21492; Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, LamTB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouviere O, Schoots IG, Wiegel T, Cornford P. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618-629. DOI:10.1016/j.eururo.2016.08.003; Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Sama-ratunga H, Zajdlewicz L, Teloken P, Dunglison N, Williams S, Lavin MF, Gardiner RA. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. 2018;19(8):1051-1060. DOI:10.1016/S1470-2045(18)30357-7; Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. JAMA. 2017;317(11):1126-1140. DOI:10.1001/ jama.2017.1704. Erratum in: JAMA. 2017;317(20):2134.; Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998;13(3):159-66. DOI:10.1046/j.1525-1497.1998.00050.x; Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250-61. doi:10.1056/NEJMoa074311; NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270(1):83-90. PMID: 8510302; Fode M, 0stergren PB, Jensen CFS, Jakobsen H, S0nksen J. Treatment effects of phosphodiesterase-5 inhibitors may improve with time following nerve-sparing radical prostatectomy. Scand J Urol. 2018;52(2):108-110. DOI:10.1080/21681805.2017.1387603; Andersson KE. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev. 2011;63(4):811-59. DOI:10.1124/pr.111.004515; Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128(3):492-7. DOI:10.1016/s0022-5347(17)53012-8; Попов С.В., Орлов И.Н., Гринь Е.А., Малевич С.М., Гулько А.М., Топузов Т.М., Кызласов П.С., Повелица Э.А. Новые технологии и подходы в диагностике и лечении эректильной дисфункции. Вестник урологии. 2020;8(2):78-92. DOI:10.21886/2308-6424-2020-8-2-78-92; Jung J, Jo HW, Kwon H, Jeong NY. Clinical neuroanatomy and neurotransmitter-mediated regulation of penile erection. Int Neurourol J. 2014;18(2):58-62. DOI:10.5213/inj.2014.18.2.58; Burnett AL, Tillman SL, Chang TS, Epstein JI, Lowenstein CJ, Bredt DS, Snyder SH, Walsh PC. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol. 1993;150(1):73-6. DOI:10.1016/S0022-5347(17)35401-0; Hedlund P, Ny L, Alm P, Andersson KE. Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase. J Urol. 2000;164(3 Pt 1):868-75. DOI:10.1016/S0022-5347(05)67329-6; Dail WG, Barba V, Leyba L, Galindo R. Neural and endothelial nitric oxide synthase activity in rat penile erectile tissue. Cell Tissue Res. 1995;282(1):109-16. DOI:10.1007/BF00319137; Domoto T, Tsumori T. Co-localization of nitric oxide synthase and vasoactive intestinal peptide immunoreactivity in neurons of the major pelvic ganglion projecting to the ratrectum and penis. Cell Tissue Res. 1994;278(2):273-8. DOI:10.1007/BF00414170; Saenz de Tejada I, Blanco R, Goldstein I, Azadzoi K, de las Morenas A, Krane RJ, Cohen RA. Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. Am J Physiol. 1988;254(3 Pt 2):H459-67. DOI:10.1152/ajpheart.1988.254.3.H459; McConnell J, Benson GS. Innervation of human penile blood vessels. Neurourol Urodyn. 1982;1:199-210 DOI:10.1002/nau.1930010213; Quinlan DM, Nelson RJ, Walsh PC. Cavernous nerve grafts restore erectile function in denervated rats. J Urol. 1991;145(2):380-3. DOI:10.1016/s0022-5347(17)38348-9; Ball RA, Lipton SA, Dreyer EB, Richie JP, Vickers MA. Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function. J. Urol. 1992;148(1):211-5. DOI:10.1016/S0022-5347(17)36555-2; Ballance CA, Ballance HA, Stewart P. Remarks on the operative treatment of chronic facial palsy of peripheral origin. Br Med J. 1903;1(2209):1009-13. DOI:10.1136/bmj.1.2209.1009; Viterbo F, Teixeira E, Hoshino K, Padovani CR. End-to-side neurorrhaphy with and without perineurium. Sao Paulo Med J. 1998;116(5):1808-14. DOI:10.1590/s1516-31801998000500005; Viterbo F, Trindade JC, Hoshino K, Mazzoni A. Two end-to-side neurorrhaphies and nerve graft with removal of the epineural sheath: experimental study in rats. Br J Plast Surg. 1994;47(2):75-80. DOI:10.1016/0007-1226(94)90162-7; Viterbo F, Trindade JC, Hoshino K, Mazzoni Neto A. Latero-terminal neurorrhaphy without removal of the epineural sheath. Experimental study in rats. Rev Paul Med. 1992;110(6):267-75. Erratum in: Rev Paul Med. 1993;111(6):479. PMID: 1341024; Matsuda K, Kakibuchi M, Kubo T, Tomita K, Fujiwara T, Hattori R, Yano K, Hosokawa K. A new model of end-to-side nerve graft for multiple branch reconstruction: end-to-side cross-face nerve graft in rats. J Plast Reconstr Aesthet Surg. 2008;61(11):1357-67. DOI:10.1016/j.bjps.2008.04.013; Okochi M, Ueda K, Okochi H, Asai E, Sakaba T, Kajikawa A. Facial reanimation using hypoglossal-facial neurorrhaphy with end-to-side coaptation between the jump interpositional nerve graft and hypoglossal nerve: Outcome and duration of preoperative paralysis. Microsurgery. 2016;36(6):460-6. DOI:10.1002/micr.22393; Viterbo F, Romao A, Brock RS, Joethy J. Facial reanimation utilizing combined orthodromic temporalis muscle flap and end-to-side cross-face nerve grafts. Aesthetic Plast Surg. 2014;38(4):788-95. DOI:10.1007/s00266-014-0357-8; Rovak JM, Cederna PS, Macionis V, Urbanchek MS, Van Der Meulen JH, Kuzon WM Jr. Termino-lateral neurorrhaphy: the functional axonal anatomy. Microsurgery. 2000;20(1):6-14. DOI:10.1002/(sici)1098-2752(2000)20:13.0.co;2-5; Hosseinian MA, Gharibi Loron A, Nemati B, Khandaghy M. Comparison of a distal end-to-side neurorrhaphy with a proximal-distal end-to-side neurorrhaphy: in a rat model. Eur J Orthop Surg Traumatol. 2015;25(8):1261-4. DOI:10.1007/s00590-015-1699-x; Kim ED, Scardino PT, Hampel O, Mills NL, Wheeler TM, Nath RK. Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. J Urol. 1999;161(1):188-92. PMID: 10037395; Kim ED, Nath R, Slawin KM, Kadmon D, Miles BJ, Scardino PT. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology. 2001;58(6):983-7. DOI:10.1016/s0090-4295(01)01403-0; Secin FP, Koppie TM, Scardino PT, Eastham JA, Patel M, Bianco FJ, Tal R, Mulhall J, Disa JJ, Cordeiro PG, Rabbani F. Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. J Urol. 2007;177(2):664-8. DOI:10.1016/j.juro.2006.09.035; Namiki S, Saito S, Nakagawa H, Sanada T, Yamada A, Arai Y. Impact of unilateral sural nerve graft on recovery of potency and continence following radical prostatectomy: 3-year longitudinal study. J Urol. 2007;178(1):212-6; discussion 216. DOI:10.1016/j.juro.2007.03.043; Nelson BA, Chang SS, Cookson MS, Smith JA Jr. Morbidity and efficacy of genitofemoral nerve grafts with radical retropubic prostatectomy. Urology. 2006;67(4):789-92. DOI:10.1016/j.urology.2005.10.004; Porpiglia F, Ragni F, Terrone C, Renard J, Musso F, Grande S, Cracco C, Ghignone G, Scarpa RM. Is laparoscopic unilateral sural nerve grafting during radical prostatectomy effective in retaining sexual potency? BJU Int. 2005;95(9):1267-71. DOI:10.1111/j.1464-410X.2005.05501.x; Davis JW, Chang DW, Chevray P, Wang R, Shen Y, Wen S, Pettaway CA, Pisters LL, Swanson DA, Madsen LT, Huber N, Troncoso P, Babaian RJ, Wood CG. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur Urol. 2009;55(5):1135-43. DOI:10.1016/j.eururo.2008.08.051; Dong C, Dong Z, Xie Z, Zhang L, Xiong F, Wen Q, Fan Z, Peng Q. Functional Restoration of Erectile Function Using End-to-side Autonomic-to-somatic Neurorrhaphy in Rats. Urology. 2016;95:108-14. DOI:10.1016/j.urology.2016.05.017; Souza Trindade JC, Viterbo F, Petean Trindade A, Favaro WJ, Trindade-Filho JCS. Long-term follow-up of treatment of erectile dysfunction after radical prostatectomy using nerve grafts and end-to-side somatic-autonomic neurorraphy: a new technique. BJU Int. 2017;119(6):948-954. DOI:10.1111/bju.13772; Haninec P, Kaiser R, Dubovy P. A comparison of collateral sprouting of sensory and motor axons after end-to-side neurorrhaphy with and without the perineurial window. Plast Reconstr Surg. 2012;130(3):609-14. DOI:10.1097/PRS.0b013e31825dc20a; Scaglione F, Donde S, Hassan TA, Jannini EA. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction: pharmacology and clinical impact of the sildenafil citrate orodispersible tablet formulation. Clin Ther. 2017;39(2):370-377. DOI:10.1016/j.clinthera.2017.01.001; https://www.urovest.ru/jour/article/view/398

Διαθεσιμότητα: https://www.urovest.ru/jour/article/view/398
https://doi.org/10.21886/2308-6424-2020-8-4-135-144

PLATELET-RICH PLASMA THERAPY FOR ERECTILE DYSFUNCTION: A REVIEW OF PRECLINICAL AND CLINICAL STUDIES ; АУТОПЛАЗМА, ОБОГАЩЕННАЯ ТРОМБОЦИТАРНЫМИ ФАКТОРАМИ РОСТА, В ЛЕЧЕНИИ ЭРЕКТИЛЬНОЙ ДИСФУНКЦИИ: ОБЗОР ДОКЛИНИЧЕСКИХ И КЛИНИЧЕСКИХ ИССЛЕДОВАНИЙ

Συγγραφείς: A. D. Kaprin, A. A. Kostin, M. V. Epifanova, M. E. Chalyy, E. V. Gameeva, S. A. Artemenko, А. Д. Каприн, А. А. Костин, М. В. Епифанова, М. Е. Чалый, Е. В. Гамеева, С. А. Артеменко

Συνεισφορές: No funding of this work has been held., Финансирование данной работы не проводилось.

Πηγή: Research and Practical Medicine Journal; Том 6, № 3 (2019); 74-86 ; Research'n Practical Medicine Journal; Том 6, № 3 (2019); 74-86 ; 2410-1893 ; 10.17709/2409-2231-2019-6-3

Θεματικοί όροι: клеточная терапия, erectile dysfunction (ED), sexual dysfunction, erectile function, regenerative medicine, growth factors, cell therapy, обогащенная тромбоцитарными факторами роста (АОТ), эректильная дисфункция (ЭД), сексуальная дисфункция, эректильная функция (ЭФ), факторы роста

Περιγραφή αρχείου: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/423/314; Colson MH, Cuzin B, Faix A, Grellet L, Huyghes E. Erectile dysfunction : up-date data and clinical guidelines. Rev Med Suisse. 2019 Mar 13;15 (642):583–589. [Article in French].; Shaeer O, Shaeer K. The Global Online Sexuality Survey (GOSS): the United States of America in 2011. Chapter I: erectile dysfunction among English-speakers. J Sex Med. 2012 Dec;9 (12):3018–27. DOI:10.1111/j.1743–6109.2012.02976.x; Shaeer O, Shaeer K, Fode M, Serefoglu E. The Global Online Sexuality Survey (GOSS) 2015. Erectile Dysfunction Among English-Speaking Internet Users in the United States. Human Andrology. 2017;7 (4):111–9.; Пушкарь Д. Ю., Камалов А. А., Аль-Шукри С .Х., Еркович А.А., Коган М.И., Павлов В.Н., Журавлев В.Н., Берников А. Н. Анализ результатов эпидемиологического исследования распространенности эректильной дисфункции в Российской Федерации. Урология. 2012;6:5–9.; Çayan S, Kendirci M, Yaman Ö, Aşçı R, Orhan İ, Usta MF, et al. Prevalence of erectile dysfunction in men over 40 years of age in Turkey: Results from the Turkish Society of Andrology Male Sexual Health Study Group. Turk J Urol. 2017 Jun;43 (2):122–129. DOI:10.5152/tud.2017.24886; Boston University School of Medicine and Sexual Medicine. Epidemiology of ED. Available at: http://www.bumc.bu.edu/sexualmedicine/physicianinformation/epidemiology-of-ed/; Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018 Sep;200 (3):633–641. DOI:10.1016/j.juro.2018.05.004; EAU Guidelines. Edn. presented at the EAU Annual Congress Copenhagen 2018. ISBN 978–94–92671–01–1.; Pastuszak AW. Current Diagnosis and Management of Erectile Dysfunction. Curr Sex Health Rep. 2014 Sep;6 (3):164–176. DOI:10.1007/s11930–014–0023–9; Priviero FB, Toque HA, Nunes KP, Priolli DG, Teixeira CE, Webb RC. Impaired Corpus Cavernosum Relaxation Is Accompanied by Increased Oxidative Stress and Up-Regulation of the Rho-Kinase Pathway in Diabetic (Db/Db) Mice. PLoS One. 2016;11 (5): e0156030. Published 2016 May 26. DOI:10.1371/journal. pone.0156030; Nehra A, Goldstein I, Pabby A, Nugent M, Huang YH, de las Morenas A, et al. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol. 1996 Oct; 156 (4):1320–9.; Moreland RB. Is there a role of hypoxemia in penile ®brosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res. 1998 Jun;10 (2):113–20.; El-Sakka AI. Reversion of penile fibrosis: Current information and a new horizon. Arab Journal of Urology. 2011;9 (1):49–55. DOI:10.1016/j.aju.2011.03.013; Castela Â, Soares R, Rocha F, Vendeira P, Virag R, Costa C. Erectile tissue molecular alterations with aging–differential activation of the p42/44 MAP Kinase pathway. Age. 2011;33 (2):119–130. DOI:10.1007/s11357–010–9167–3; Lindau ST, Tang H, Gomero A, Vable A, Huang ES, Drum ML, et al. Sexuality among middle-aged and older adults with diagnosed and undiagnosed diabetes: a national, population-based study. Diabetes Care. 2010 Oct;33 (10):2202–10. DOI:10.2337/dc10–0524; Guo W, Liao C, Zou Y, Li F, Li T, Zhou Q, et al. Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies. J Sex Med. 2010 Aug;7 (8):2805–16. DOI:10.1111/j.1743–6109.2010.01792.x; Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005 Dec 21;294 (23):2996–3002. DOI:10.1001/jama.294.23.2996; Loprinzi PD and Nooe A. Erectile dysfunction and mortality in a national prospective cohort study. J Sex Med. 2015 Nov;12 (11):2130–3. DOI:10.1111/jsm.13032; Чалый М.Е., Григ орян В.А., Епиф анова М.В., К рас-нов А.О. Эффективность интракавернозного введения аутоплазмы, обогащенной тромбоцитами, в лечении эректильной дисфункции. Урология. 2015;4:76–9.; Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, Lee Y. Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast. Ann Dermatol. 2011 Nov;23 (4):424–31. DOI:10.5021/ad.2011.23.4.424; Lee JW, Kwon OH, Kim TK, Cho YK, Choi KY, Chung HY, et al. Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups. Arch Plast Surg. 2013 Sep;40 (5):530–5. DOI:10.5999/aps.2013.40.5.530.; Cameli N, Mariano M, Cordone I, Abril E, Masi S, Foddai ML. Autologous Pure Platelet-Rich Plasma Dermal Injections for Facial Skin Rejuvenation: Clinical, Instrumental, and Flow Cytometry Assessment. Dermatol Surg. 2017 Jun;43 (6):826–835. DOI:10.1097/DSS.0000000000001083; Anitua E, Muruzabal F, de la Fuente M, Merayo J, Durán J, Orive G. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases. Curr Eye Res. 2016 Jul;41 (7):875–82. DOI:10.3109/02713683.2015.1104362.; Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-Rich Plasma From Basic Science to Clinical Applications. Am J Sports Med. 2009 Nov;37 (11):2259–72. DOI:10.1177/0363546509349921; Daif ET. Effect of autologous platelet-rich plasma on bone regeneration in mandibular fractures. Dent Traumatol. 2013 Oct;29 (5):399–403. DOI:10.1111/edt.12021.; Sadeghi-Ataabadi M, Mostafavi-Pour Z, Vojdani Z, Sani M, Latifi M, Talaei-Khozani T. Fabrication and characterization of platelet-rich plasma scaffolds for tissue engineering applications. Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:372–380. DOI:10.1016/j.msec.2016.10.001; Anjayani S, Wirohadidjojo YW, Adam AM, Suwandi D, Seweng A, Amiruddin MD. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. Int J Dermatol. 2014 Jan;53 (1):109–13. DOI:10.1111/ijd.12162.; Teymur H, Tiſtikcioglu YO, Cavusoglu T, Tiſtikcioglu BI, Erbas O, Yigitturk G, Uyanikgil Y. Effect of platelet-rich plasma on reconstruction with nerve autograſts. Kaohsiung J Med Sci. 2017 Feb;33 (2):69–77. DOI:10.1016/j.kjms.2016.11.005; Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers. Ann Vasc Surg. 2017 Jan;38:206–211. DOI:10.1016/j.avsg.2016.04.023; Patel AN, Selzman CH, Kumpati GS, McKellar SH, Bull DA. Evaluation of autologous platelet rich plasma for cardiac surgery: outcome analysis of 2000 patients. J Cardiothorac Surg. 2016 Apr 12;11 (1):62. DOI:10.1186/s13019–016–0452–9; Taschieri S, Lolato A, Ofer M, Testori T, Francetti L, Del Fabbro M. Immediate post-extraction implants with or without pure platelet-rich plasma: a 5-year follow-up study. Oral Maxillofac Surg. 2017 Jun;21 (2):147–157. DOI:10.1007/s10006–017–0609–2; Smith PA. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis An FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med. 2016 Apr;44 (4):884–91. DOI:10.1177/0363546515624678; Kumar CS. Combined Treatment of Injecting Platelet Rich Plasma With Vacuum Pump for Penile Enlargement. The Journal of Sexual Medicine. 2017;14 (1) :S78.; Banno JJ, Kinnick TR, Roy L, Perito P, Antonini G, Banno D. The Efficacy of Platelet-Rich Plasma (PRP) as a Supplemental Therapy for the Treatment of Erectile Dysfunction (ED): Initial Outcomes. The Journal of Sexual Medicine. 2017;14 (2 ):e59-e60.; Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009 Mar;27 (3):158–67. DOI:10.1016/j. tibtech.2008.11.009; Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular Endothelial Growth Factor and Angiogenesis. Pharmacol Rev. 2004;56:549–580.; Raica M, Cimpean AM. Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy. Pharmaceuticals (Basel). 2010 Mar 11;3 (3):572–599. DOI:10.3390/ph3030572; Murakami M, Simons M. Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol. 2008 May;15 (3):215–20. DOI:10.1097/MOH.0b013e3282f97d98; van Cruijsen H, Giaccone G, Hoekman K. Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies. Int J Cancer. 2005 Dec 20;117 (6):883–8. DOI:10.1002/ijc.21479; Jacobo SM, Kazlauskas A. Insulin-like Growth Factor 1 (IGF-1) Stabilizes Nascent Blood Vessels. J Biol Chem. 2015 Mar 6;290 (10):6349–60. DOI:10.1074/jbc.M114.634154; Viñals F, Pouysségur J. Transforming Growth Factor β1 (TGF-β1) Promotes Endothelial Cell Survival during In Vitro Angiogenesis via an Autocrine Mechanism Implicating TGF-α Signaling. Mol Cell Biol. 2001 Nov;21 (21):7218–30. DOI:10.1128/MCB.21.21.7218–7230.2001; Sclafani AP. Applications of platelet-rich fibrin matrix in facial plastic surgery. Facial Plast Surg. 2009 Nov;25 (4):270–6. DOI:10.1055/s-0029–1242033; Middleton KK, Barro V, Muller B, Terada S, Fu FH. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soſt tissue injuries. Iowa Orthop J. 2012;32:150–63.; Scarcia M, Maselli FP, Cardo G, Ludovico GM. The use of autologous platelet rich plasma gel in bulbar and penile buccal mucosa urethroplasty: Preliminary report of our first series. Arch Ital Urol Androl. 2016 Dec 30;88 (4):274–278. DOI:10.4081/aiua.2016.4.274.; French WJ, Creemers EE, Tallquist MD. Platelet-derived growth factor receptors direct vascular development independent of vascular smooth muscle cell function. Mol Cell Biol. 2008 Sep;28 (18):5646–57. DOI:10.1128/MCB.00441–08; Chen N-F, Sung C-S, Wen Z-H, Chen CH, Feng CW, Hung HC, et al. Therapeutic Effect of Platelet-Rich Plasma in Rat Spinal Cord Injuries. Front Neurosci. 2018 Apr 23;12:252. DOI:10.3389/fnins.2018.00252; Zhang J, Middleton KK, Fu FH, Im H-J, Wang JH-C. HGF Mediates the Anti-inflammatory Effects of PRP on Injured Tendons. PLoS One. 2013 Jun 28;8 ( 6):e67303. DOI:10.1371/journal. pone.0067303; Wu CC, Wu YN, Ho H.O., Chen KC, Sheu MT, Chiang HS. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J Sex Med. 2012 Nov;9 (11):2838–48. DOI:10.1111/j.1743–6109.2012.02881.x; Xie D, Pippen AM, Odronic SI, Annex BH, Donatucci CF. Intracavernosal basic fibroblast growth factor improves vasoreactivity in the hypercholesterolemic rabbit. J Sex Med. 2006 Mar;3 (2):223–32. DOI:10.1111/j.1743–6109.2005.00174.x; Dai Q, Silverstein AD, Davies MG, Hagen PO, Donatucci CF, Annex BH. Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. J Urol. 2003 Aug;170 (2 Pt 1):664–8. DOI:10.1097/01.ju.0000065247.55066.ad; Suetomi T, Hisasue S, Sato Y, Tabata Y, Akaza H, Tsukamoto T. Effect of basic fibroblast growth factor incorporating gelatin microspheres on erectile function in the diabetic rat. J Urol. 2005 Apr;173 (4):1423–8. DOI:10.1097/01. ju.0000149034.49289.2b; Ding XG, Li SW, Zheng XM, Hu LQ, Hu WL, Luo Y. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl. 2009 Mar;11 (2):215–21. DOI:10.1038/aja.2008.37; Wu YN, Wu CC, Sheu MT, Chen KC, Ho HO, Chiang HS. Opti-mization of platelet-rich plasma and its effects on the recovery of erectile function aſter bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med. 2016 Oct;10 ( 10):E294-E304. DOI:10.1002/term.1806; ChunHou Liao, YiNo Wu, HanSun Chiang. MP43–09 Effects of platelet rich plasma on improving erectile dysfunction in streptozotocin-induced diabetic rats. The Journal of Urology. 2018;199 (4S).; Reinders Y, Felthaus O, Brockhoff G, Pohl F, Ahrens N, Prantl L, Haubner F. Impact of Platelet-Rich Plasma on Viability and Proliferation in Wound Healing Processes aſter External Radiation. Int J Mol Sci. 2017 Aug 22;18 (8). pii: E1819. DOI:10.3390/ijms18081819; RF Patent No. 2514639 for invention «Method of treating erectile dysfunction» (Inventors : Chalyy M.E ., Vilkin Y.F. Epifanova M.V.). Moscow. Granted March 5, 2014.; Глыбочко П.В., Чалый М. Е., Епифанова М. В., Ахвледиан и Н.Д., Краснов А.О. Применение аутоплазмы, обогащенной тромбоцитарными факторами роста, в лечении эректильной дисфункции. Урология. 2015;1:100–3. DOI:10.18565/urol.2017.4.46– 48; Епиф анова М.В., Ч алый М.Е., Краснов А.О. Исследование механизмов действия факторов роста в аутоплазме, обогащенной тромбоцитами, применяемой для лечения эректильной дисфункции. Урология. 2017;4:46–8.; Alkhayal S, Lourdes M. Corporeal rejuvenation with platelet rich plasma as a treatment for erectile dysfunction. Proceedings of the 21st World Meeting on Sexual Medicine. July 2018. Volume 15, Issue 7, Supplement 3, Page S254; Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018 Jan;59 (1):61–65. DOI:10.4111/icu.2018.59.1.61; https://www.rpmj.ru/rpmj/article/view/423

Διαθεσιμότητα: https://www.rpmj.ru/rpmj/article/view/423
https://doi.org/10.17709/2409-2231-2019-6-3-7

Effectiveness and safety of Tadalafil-SZ (NJSC “Northern Star”) at 5 mg / day in patients with symptoms of voiding dysfunction due to prostatic hyperplasia ; Эффективность и безопасность применения «Тадалафила-СЗ» (НАО «Северная звезда») в дозе 5 мг / сут у больных с симптомами нарушенного мочеиспускания, обусловленными гиперплазией предстательной железы

Συγγραφείς: L. G. Spivak, M. S. Evdokimov, D. G. Tsarichenko, Yu. L. Demidko, D. D. Yagudaev, D. O. Korolev, L. M. Rapoport, Л. Г. Спивак, М. С. Евдокимов, Д. Г. Цариченко, Ю. Л. Демидко, Д. Д. Ягудаев, Д. О. Королев, Л. М. Рапопорт

Πηγή: Andrology and Genital Surgery; Том 20, № 3 (2019); 72-77 ; Андрология и генитальная хирургия; Том 20, № 3 (2019); 72-77 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2019-20-3

Θεματικοί όροι: тадалафил, prostatic hyperplasia, erectile function, tadalafil, гиперплазия предстательной железы, эректильная функция

Περιγραφή αρχείου: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/369/336; Welch G., Weinger K., Barry M.J. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-Up Study. Urology 2002;59(2):245–50. DOI:10.1016/s0090-4295(01)01506-0.; Trueman P., Hood S.C., Nayak U.S., Mrazek M.F. Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999;83(4):410–5.; Berry S.J., Coffey D.S., Walsh P.C., Ewing L.L. The development of human benign prostatic hyperplasia with age. J Urol 1984;132(3):474–9. DOI:10.1016/s0022-5347(17)49698-4.; Gravas S., Cornu J.N., Drake M.J. et al. EAU guidelines on management of nonneurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) 2018. In: European Association of Urology guidelines 2018 edition. Arnhem: European Association of Urology Guidelines Office, 2018.; Gacci M., Andersson K.E., Chapple C. et al. Latest evidence on the use of phosphodiesterase type 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2016;70(1):124–33. DOI:10.1016/j.eururo.2015.12.048.; Gacci M., Corona G., Salvi M. et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2012;61(5):994–1003. DOI:10.1016/j.eururo.2012.02.033.; Park H.J., Won J.E., Sorsaburu S. et al. Urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and LUTS/BPH with erectile dysfunction in Asian men: a systematic review focusing on tadalafil. World J Mens Health 2013;31(3):193–207.; Won J.E., Chu J.Y., Choi H.C. et al. Safety and effectiveness of once-daily tadalafil (5 mg) therapy in Korean men with benign prostatic hyperplasia/lower urinary tract symptoms in a real-world clinical setting: results from a postmarketing surveillance study. World J Mens Health 2018;36(2):161–70. DOI:10.5534/wjmh.17017.; Oelke M., Shinghal R., Sontag A. et al. Time to onset of clinically meaningful improvement with tadalafil 5 mg once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: analysis of data pooled from 4 pivotal, double-blind, placebo controlled studies. J Urol 2015;193(5):1581–9. DOI:10.1016/j.juro.2014.11.094.; Broderick G.A., Brock G.B., Roehrborn C.G. et al. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction. Urology 2010;75(6):1452–8. DOI:10.1016/j.urology.2009.09.093.; Dong Y., Hao L., Shi Z. et al. Efficacy and safety of tadalafil monotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a metaanalysis. Urol Int 2013;91(1):10–8. DOI:10.1159/000351405.; Porst H., Kim E.D., Casabe A.R. et al. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, doubleblind, placebo-controlled trial. Eur Urol 2011;60(5):1105–13. DOI:10.1016/j.eururo.2011.08.005.; https://agx.abvpress.ru/jour/article/view/369

Διαθεσιμότητα: https://agx.abvpress.ru/jour/article/view/369
https://doi.org/10.17650/2070-9781-2019-20-3-72-77

Erectile function after endoscopic surgery for prostatic hyperplasia removal ; Эректильная функция после эндоскопических операций по удалению гиперплазии предстательной железы

Συγγραφείς: P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, D. V. Enikeev, N. D. Akhvlediani, L. G. Spivak, Ya. N. Chernov, E. A. Laukhtina, A. V. Dymova, M. S. Taratkin, П. В. Глыбочко, Ю. Г. Аляев, Л. М. Рапопорт, Д. В. Еникеев, Н. Д. Ахвледиани, Л. Г. Спивак, Я. Н. Чернов, Е. А. Лаухтина, А. В. Дымова, М. С. Тараткин

Πηγή: Andrology and Genital Surgery; Том 18, № 4 (2017); 12-18 ; Андрология и генитальная хирургия; Том 18, № 4 (2017); 12-18 ; 2412-8902 ; 2070-9781 ; 10.17650/2070-9781-2017-18-4

Θεματικοί όροι: эректильная функция, benign prostatic hyperplasia, transurethral resection, thulium and holmium laser enucleation, infravesical obstruction, erectile function, доброкачественная гиперплазия предстательной железы, трансуретральная резекция, тулиевая и гольмиевая лазерная энуклеация, инфравезикальная обструкция

Περιγραφή αρχείου: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/255/238; Vuichoud C., Loughlin R. K. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015;22:1–6. PMID: 26497338.; Rosen R., Altweinb J., Boylec P. et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637–49. PMID: 14644114.; Gacci M., Bartoletti R., Figlioli S. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study. Br J Urol Int 2003;91:196–200. PMID: 12581003.; Cha J. S., Park J. K. Association between lower urinary tract symptoms and erectile dysfunction. Korean J Urol 2005;46:1023–7.; Jung J. H., Jae S. U., Kam S. C., Hyun J. S. Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function. J Sex Med 2009;6:2299–304. DOI:10.1111/j.1743- 6109.2009.01324.x. PMID: 19493292.; Tscholl R., Largo M., Poppinghaus H. et al. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995;153(5):1491–3. PMID: 7536253.; Hanbury D., Sethia K. Erectile function following transurethral prostatectomy. Br J Urol 1995;75:12–3. PMID: 7850292.; Bieri S., Iselin C. E., Rohner S. Capsular perforation localization and adenoma size as prognosis indicator of erectile dysfunctional after transurethral prostatectomy. Scand J Urol Nephrol 1997;31(6):545–8. PMID: 9458513.; Choi S. B., Zhao C., Park J. K. The effect of transurethral resection of the prostate on erectile function in patients with benign prostatic hyperplasia. Korean J Urol 2010;51(8):557560. DOI:10.4111/kju.2010.51.8.557. PMID: 20733962.; Gravas S., Bach T., Bachmann A. et al. EAU Guidelines on Management of Non- Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). Eur Assoc Urol, 2016. Available at: http://uroweb.org/wpcontent/uploads/EAU-Guidelines-Management-of-non-neurogenic-male-LUTS-2016. pdf.; Soderdahl D. W., Knight R. W., Hansberry K. L. Erectile dysfunction following transurethral resection of the prostate. J Urol 1996;156:1354–6. PMID: 8808870.; Taher A. Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors. World J Urol 2004;22:457–60. DOI:10.1007/s00345‑004‑0449‑1. PMID: 15503048.; Miner M., Rosenberg M. T., Perelman M. A. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function. Clin Ther 2006;28:13–25. DOI:10.1016/j.clinthera. 2006.01.004. PMID: 16490576.; Elshal A. M., El-Assmy A., Mekkawy R. et al. Prospective controlled assessment of men’s sexual function changes following Holmium laser enucleation of the prostate for treatment of benign prostate hyperplasia. Int Urol Nephrol 2017;49(10):1741–9. DOI:10.1007/s11255‑017‑1649‑0. PMID: 28780626.; Ефремов Е. А., Дорофеев С. Д. Эректильная дисфункция у пациентов, перенесших трансуретральные эндоскопические оперативные вмешательства на предстательной железе по поводу ее доброкачественной гиперплазии. Русский медицинский журнал. Хирургия. Урология 2004;12(8(208)):527–33. [Efremov E.A., Dorofeev S.D. Erectile dysfunction in patients after transurethral endoscopic operative interventions on the prostate due to its benign hyperplasia. Russkiy meditsinskiy zhurnal. Khirurgiya. Urologiya = Russian Medical Journal. Surgery. Urology 2004;12(8(208)):527–33. (In Russ.)].; Muntener M., Aellig S., Kuettel R. et al. Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol 2007;52: 510–6. DOI:10.1016/j.eururo.2007.01.088. PMID: 17306446.; Rassweiler J., Teber D., Kuntz R., Hofmann R. Complications of transurethral resection of the prostate (TURP) – incidence, management and prevention. Eur Urol 2006;50:969–80. DOI:10.1016/j.eururo.2005.12.042. PMID: 16469429.; Аляев Ю. Г., Винаров А. З., Чалый М. Е. и др. Причины эректильной дисфункции после трансуретральной резекции гиперплазированной предстательной железы и ее профилактика. Урология 2005;3:28–32. [Alyaev Yu. G., Vinarov A. Z., Chaliy M. E. et al. Causes of erectile dysfunction after transurethral resection of hyperplastic prostate and its prevention. Urologiya = Urology 2005;3:28–32. (In Russ.)].; Bishop P. Bipolar transurethral resection of the prostate – a new approach. AORN J 2003;77(5):979–83. PMID: 12769328.; D’elia G., Mastrangeli B. A randomized prospective trial of bipolar versus standard monopolar transurethral resection of the prostate. Abstracts Book of the XIXth Congress of EAU, Vienna 2004, A. 113.; Eaton A. C., Francis R. N. The provision of transurethral prostatectomy on a daycase basis using bipolar plasma kinetic technology. BJU Int 2002;89(6):534. PMID: 11942959.; Xie J. B., Tan Y. A., Wang F. L. Extraperitoneal laparoscopic adenomectomy (Madigan) versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia greater than 80 ml: complications and functional outcomes after 3-year follow-up. J Endourol 2014;28:353–9. DOI:10.1089/end.2013.0374. PMID: 24229434.; Pu X., Wang X., Wang H., Hu L. Erectile dysfunction after PlasmaKinetic vaporization of the prostate: incidence and risk factors. J Endourol 2006;20(9):693–7. DOI:10.1089/end.2006.20.693. PMID: 16999629.; Аlloussi S. H., Lang C., Eichel R., Alloussi S. Ejaculation-preserving transurethral resection of prostate and bladder neck: short-and long-term results of a new innovative resection technique. J Endourol 2014;28:84–9. DOI:10.1089/end.2013.0093. PMID: 23952037.; Mamoulakis C., Trompetter M., de la Rosette J. Bipolar transurethral resection of the prostate: The “golden standard” reclaims its leading position. Curr Opin rol 2009;19:26–32. DOI:10.1097/MOU.0b013e32831e44da. PMID: 19057207.; Kabalin J. N. Laser prostatectomy performed with a right angle firing neodymium: YAG laser fiber at 40 watts power setting. J Urol 1993;150:95–9. PMID: 7685429.; Norris J. P., Norris D. M., Lee R. D., Rubenstein M. A. Visual laser ablation of the prostate: clinical experience in 108 patients. J Urol 1993;150:1612–4. PMID: 7692096.; Keoghane S. R., Lawrence K. C., Gray A. M. et al. A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up. BJU Int 2000;85(1):74–8. PMID: 10619950.; Maheshwari P. N., Joshi N., Maheshwari R. P. Best laser for prostatectomy in the year 2013. Indian J Urol 2013;29(3):236–43. DOI:10.4103/0970-1591.117286. PMID: 24082446.; Kuntz R. M. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006;49:961–9. DOI:10.1016/j.eururo.2006.03.028. PMID: 16632179.; Misraï V., Rouprêt M., Guillotreau J. et al. Greenlight photoselective vaporisation for benign prostatic hyperplasia: a systematic review. Prog Urol 2013;23(2):77–87. DOI:10.1016/j.purol.2012.10.013. PMID: 23352299.; Bruyere F., Puichaud A., Pereira H. et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010;58:207–11. DOI:10.1016/j.eururo.2010.04.027. PMID: 20466480.; Elshal A. M., Elkoushy M. A., Elmansy H. M. et al. Holmium: YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate. J Urol 2014;191:148–54. DOI:10.1016/j.juro.2013.06.113. PMID: 23845460.; Guo Z., Jin X. The volume of prostate can impact the male sexual function following photoselective vaporization of the prostate: results of a prospective analysis of 128 patients with 2-year follow-up. Int Urol Nephrol 2013;45(4):961–6. DOI:10.1007/s11255‑013‑0489‑9. PMID: 23779228.; Kuo R. L., Kim S. C., Lingeman J. E. et al. Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75 gram enucleations. J Urol 2003;170:149–52. DOI:10.1097/01.ju.0000070686.56806.a1. PMID: 12796668.; Глыбочко П. В., Аляев Ю. Г., Рапопорт Л. М. и др. Гольмиевая лазерная энуклеация гиперплазии предстательной железы: технические аспекты. Андрология и генитальная хирургия 2015;16(4):62–6. DOI:10.17650/2070‑9781‑2015‑16‑4‑62‑66. [Glybochko P. V., Alyaev Yu. G., Rapoport L. M. et al. Holmium laser enucleation of the prostate hyperplasia: technical aspects. Andrologiya i genitalnaya khirurgiya = Andrology and Genital Surgery 2015;16(4):62–6. DOI:10.17650/2070‑9781‑2015‑16‑4‑62‑66. (In Russ.)].; Placer J., Salvador C., Planas J. et al. Effects of holmium laser enucleation of the prostate on sexual function. J EndoUrol 2015;29:332–9. DOI:10.1089/end.2014.0502. PMID: 25133981.; Glybochko P., Alyaev Yu., Rapoport L. et al. Effect of Holmium Lazer Enucleation of the prostate (HoLEP) on the Sexual Function. J Urol 2017;197:499. DOI: http://dx.doi.org/10.1016/j.juro.2017.02.1071.; Elshal A. M., Elmansy H. M., Elkoushy M. A. Male sexual function outcome after three laser prostate surgical techniques: A single center perspective. Urology 2012;80:1098–104. DOI:10.1016/j.urology.2012.08.001. PMID: 23107401.; Capogrosso P., Ventimiglia E., Ferrari M. et al. Long-term sexual outcomes after holmium laser enucleation of the prostate: which patients could benefit the most? Int J Impot Res 2016;28(5):189–93. DOI:10.1038/ijir.2016.29. PMID: 27465782.; Jeong M. S., Ha S. B., Lee C. J. et al. Serial changes in sexual function following Holmium laser enucleation of the prostate: a short-term follow-up study. Korean J Urol 2012;53(2):104–8. DOI:10.4111/kju.2012.53.2.104. PMID: 22379589.; Briganti A., Naspro R., Gallina A. et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2- center, randomized trial. J Urol 2006;175:1817–21. DOI:10.1016/S0022-5347(05)00983-3. PMID: 16600770.; Meng F., Gao B., Fu Q. et al. Change of sexual function in patients before and after Ho:YAG laser enucleation of the prostate. J Androl 2007;28:259–61. DOI:10.2164/jandrol.106.000372. PMID: 17021335.; Еникеев Д. В., Глыбочко П. В., Аляев Ю. Г. и др. Лазерная энуклеация гиперплазии простаты (HOLEP и THULEP): сравнительный анализ эффективности при лечении рецидивов гиперплазии простаты. Урология 2017;4:152–6. DOI:10.18565/urol.2017.4.50-4. [Enikeev D. V., Glybochko P. V., Alyaev Yu. G. et al. Laser enucleation of the prostate (HOLEP and THULEP): a comparative effectiveness analysis in treating recurrent prostatic hyperplasia. Urologiya = Urology 2017;4:152–6. DOI:10.18565/urol.2017.4.50-4. (In Russ.)].; Saredi G., Pacchetti A., Pirola G. M. et al. Impact of thulium laser enucleation of the prostate on erectile, ejaculatory and urinary functions. Urol Int 2016;97(4): 397–401. DOI:10.1159/000446829. PMID: 27463971.; Carmignani L., Bozzini G., Macchi A. et al. Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia. Asian J Androl 2015;17(5):802–6. DOI:10.4103/1008-682X.139255. PMID: 25652616.; Iacono F., Prezioso D., Lauro G. et al. Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients. BMC Surg 2012;12(Suppl 1):21. DOI:10.1186/1471‑2482‑12-S1-S21. PMID: 23173611.; Chung J. S., Park S. H., Oh C. K. et al. Longitudinal changes in erectile function after thulium: YAG prostatectomy for the treatment of benign prostatic obstruction: a 1-year follow-up study. Lasers Med Sci 2017;32(7):1517–23. DOI:10.1007/s10103‑017‑2273-z. PMID: 28685201.; Tiburtius C., Knipper S., Gross A. J., Netsch C. Impact of thulium VapoEnucleation of the prostate on erectile function: a prospective analysis of 72 patients at 12-month follow-up. Urology 2014;83:175–80. DOI:10.1016/j.urology.2013.08.029. PMID: 24103563.; https://agx.abvpress.ru/jour/article/view/255

Διαθεσιμότητα: https://agx.abvpress.ru/jour/article/view/255
https://doi.org/10.17650/2070-9781-2017-18-4-12-18

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2)

Συγγραφείς: S. Y. Martsevich, S. N. Tolpigina

Πηγή: Рациональная фармакотерапия в кардиологии, Vol 8, Iss 5, Pp 626-635 (2015)

Θεματικοί όροι: артериальная гипертония, избыточная масса тела, ожирение, метаболические эффекты, эректильная функция, бета-адреноблокаторы, карведилол, бисопролол, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701

Περιγραφή αρχείου: electronic resource

Relation: http://www.rpcardio.ru/jour/article/view/574; https://doaj.org/toc/1819-6446; https://doaj.org/toc/2225-3653

Σύνδεσμος πρόσβασης: https://doaj.org/article/a1595d1314544361a6cc4866fa410bfb

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2)

Συγγραφείς: S. Y. Martsevich, S. N. Tolpigina

Πηγή: Рациональная фармакотерапия в кардиологии, Vol 8, Iss 5, Pp 626-635 (2015)

Θεματικοί όροι: 0301 basic medicine, 2. Zero hunger, arterial hypertension, obesity, бета-адреноблокаторы, beta-adrenoblockers, RM1-950, carvedilol, метаболические эффекты, 3. Good health, артериальная гипертония, карведилол, 03 medical and health sciences, эректильная функция, 0302 clinical medicine, ожирение, RC666-701, избыточная масса тела, metabolic effects, bisoprolol, overweight, Diseases of the circulatory (Cardiovascular) system, erectile function, Therapeutics. Pharmacology, бисопролол

Σύνδεσμος πρόσβασης: http://www.rpcardio.com/jour/article/download/574/595
https://doaj.org/article/9957cb78c9754bfebf7dd713654435e1
https://doaj.org/article/a1595d1314544361a6cc4866fa410bfb

Состояние андрогенного обеспечения и эректильной функции у мужчин, больных сахарным диабетом 2-го типа с ожирением

Πηγή: Health of Man; № 4 (2018); 76-80
Здоровье мужчины; № 4 (2018); 76-80
Здоров'я чоловіка; № 4 (2018); 76-80

Θεματικοί όροι: 2. Zero hunger, 03 medical and health sciences, 0302 clinical medicine, 616.379-008.64:616-009:616.69, diabetes mellitus, testosterone, erectile function, man, сахарный диабет, тестостерон, эректильная функция, мужчина, цукровий діабет, еректильна функція, чоловік, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://health-man.com.ua/article/view/171746

Аналіз використання інтегральних комбінацій ефективності радикальної простатектомії та оцін. нов. способу формування везико-уретрального анастамозу при ендоскопічній радикальній простатектомії у хворих на клінічно локалізований рак передміхурової залози

Πηγή: Health of Man; № 4(63) (2017); 16-29
Здоровье мужчины; № 4(63) (2017); 16-29
Здоров'я чоловіка; № 4(63) (2017); 16-29

Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, prostate cancer, radical prostatectomy, trifecta, pentafecta, octafecta, SCP system, urinary incontinence, erectile function, positive surgical margin, рак предстательной железы, радикальная простатэктомия, трифекта, пентафекта, октафекта, система SCP, недержание мочи, эректильная функция, положительный хирургический край, рак передміхурової залози, радикальна простатектомія, нетримання сечі, еректильна функція, позитивний хірургічний край, 616.65-006.6-089-06, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://health-man.com.ua/article/view/123476

Сравнение влияния длительной терапии, основанной на карведилоле и бисопрололе, на метаболические параметры и эректильную функцию у больных артериальной гипертонией и избыточной массой тела или ожирением: результаты рандомизированного, открытого, параллельного, ступенчатого исследования кабриолет

Συγγραφείς: Марцевич, С., Толпыгина, С.

Θεματικοί όροι: АРТЕРИАЛЬНАЯ ГИПЕРТОНИЯ, ИЗБЫТОЧНАЯ МАССА ТЕЛА, ОЖИРЕНИЕ, МЕТАБОЛИЧЕСКИЕ ЭФФЕКТЫ, ЭРЕКТИЛЬНАЯ ФУНКЦИЯ, β‑БЛОКАТОРЫ, КАРВЕДИЛОЛ, БИСОПРОЛОЛ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/sravnenie-vliyaniya-dlitelnoy-terapii-osnovannoy-na-karvedilole-i-bisoprolole-na-metabolicheskie-parametry-i-erektilnuyu-funktsiyu-u-1
http://cyberleninka.ru/article_covers/15451818.png